Occupational exposure limits   approaches and criteria : Proceedings from a NIVA course held in Uppsala, Sweden, 24-28 September 2001 by Johanson, Gunnar
arbete och hälsa  |  vetenskaplig skriftserie
isbn 91-7045-698-4 issn 0346-7821
nr 2003:17
Occupational exposure limits
– approaches and criteria
Proceedings from a niva course held in Uppsala, Sweden,
24–28 September 2001
Gunnar Johanson (Ed.)
National Institute for Working Life
ARBETE OCH HÄLSA
Editor-in-chief: Staffan Marklund
Co-editors: Marita Christmansson, Birgitta Meding,
Bo Melin and Ewa Wigaeus Tornqvist
© National Institut for Working Life & authors 2003
National Institute for Working Life
S-113 91 Stockholm
Sweden
ISBN 91–7045–698–4
ISSN 0346–7821
http://www.arbetslivsinstitutet.se/
Printed at Elanders Gotab, Stockholm
Arbete och Hälsa
Arbete och Hälsa (Work and Health) is a
scientific report series published by the
National Institute for Working Life. The
series presents research by the Institute’s
own researchers as well as by others, both
within and outside of Sweden.  The series
publishes scientific original works, disser-
tations, criteria documents and literature
surveys.
Arbete och Hälsa has a broad target-
group and welcomes articles in different
areas. The language is most often English,
but also Swedish manuscripts are
welcome.
Summaries in Swedish and English as well
as the complete original text are available
at www.arbetslivsinstitutet.se/ as from
1997.
Foreword
This volume of Arbete och Hälsa contains the proceedings of the Nordic Institute
for Advanced Training in Occupational Health (NIVA) course Occupational
exposure limits – approaches and criteria, third international course, held in
Uppsala, Sweden, 24-28 September, 2001. The course was planned by the Nordic
Expert Group for Criteria Documentation of Health Risks from Chemicals (NEG).
The main objectives were to: describe and differentiate between the various
approaches and criteria used to set an occupational exposure limit (OEL), identify
the problems of comparing OELs from different countries, and analyse an OEL
based on background information.
A variety of occupations were represented, including administrators, chemists,
occupational physicians and hygienists, researchers, and toxicologists. Seven
lecturers, all with profound experience of criteria work, attended the entire course
and participated actively during lecture sessions as well as group work sessions.
The multitude of nationalities and disciplines represented among participants
and lecturers created a good basis for exchange of experiences and thoughts.
The participants were asked to bring with them to the course a poster that
briefly described the OEL setting process in the participant's country. These
posters were at display along the entire course, were frequently visited during
intervals and breaks, and gave rise to several spontaneous discussions. During
the last session of the course, the posters were used as a starting point to compare
the OEL procedures in European countries, the EU and the US.
A main task during the week was to prepare a short summary document for a
selected substance. The document should contain the scientific basis for an OEL
and include a recommended health-based OEL and any other recommendations,
such as skin notation. The efforts of these group works were presented and
discussed during the last day of the course.
The following pages contain summaries of most lectures given. Although they
do not cover the entire course, I believe the text may serve as valuable reference
material for a variety of users.
On behalf of NEG, I want to express my gratitude to all the lecturers and
participants for contributing to a successful course. Special thanks to Gunilla Rasi
at NIVA, Helsinki, for excellent course administration, and to Anna-Karin
Alexandrie at the National Institute for Working Life, Stockholm, for skilful technical
editing of this volume.
Stockholm December 23, 2003
Gunnar Johanson, Professor
Course leader, Chairman of NEG
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1Basic concepts in toxicological risk
assessment
Gunnar Johanson, Work Environment Toxicology, Institute of Environmental
Medicine, Karolinska Institutet, Stockholm, Sweden, www.imm.ki.se and
www.nordicexpertgroup.org e-mail: Gunnar.Johanson@imm.ki.se
Introduction
This presentation aims to briefly describe some of the most important, basic
concepts in toxicological risk assessment. Toxicology has a multidisciplinary
character and it is neither possible to cover all concepts, nor to describe them in
detail. For this purpose the interested reader is referred to textbooks such as
Casarett and Doull’s Toxicology (2) and Stacey’s Occupational Toxicology (3),
to mention some. Many of the concepts included in this presentation can also be
found in the ILO Encyclopaedia (1). Another good starting point is the Toxico-
logy Tutor developed by the US National Library of Medicine available at
http://sis.nlm.nih.gov/Tox/ToxMain.html.
Toxicity, hazard and risk
Toxicology is the science of poisons and their effects, and with the problem areas
involved (as denoted by the terms: clinical, industrial, and regulatory toxicology).
It could also be described as the scientific study of poisons, their actions, their
detection, and the treatment of conditions produced by them. Occupational
toxicology deals with chemical substances present in the work environment.
These chemicals need not necessarily be considered as poisons, i.e. very toxic.
The words toxic, toxicology etc. are derived from toxon (Greek for bow, later
toxicum, Latin for poison (on bow)) and logos (Greek for reason or word).
Most chemicals studied in toxicology are foreign to the body, these are called
xenobiotics.
Toxicity is the intrinsic capacity of a substance to adversely affect an organism.
It can also be described as the quality or degree of a substance being poisonous.
Hazard is the potential for the toxicity to be realized in a specific situation.
Expressed in another way, hazard is a potentially dangerous condition as a result
of exposure to a substance during a specific situation or at a specific site.
Risk is the probability of a specific adverse effect to occur as a result of this
exposure.
2Risk assessment and risk management
Toxicological risk assessment is the process of describing the toxicity, hazard and
risk of a chemical substance or product. The outcome of the risk assessment is
often a so-called criteria document. Important input data categories can be animal
data on toxicity and mechanisms, in vitro data on toxicity and mechanisms, case
reports, epidemiological studies, and experimental human volunteer data on
toxicokinetics and toxicodynamics.
Risk management deals with the actions taken to reduce the risks. Risk assess-
ment and management may also deal with other risks that are not discussed here,
such as those of economic investments, traffic accidents, work procedures etc.
Risk analysis is a broader term that includes risk assessment, risk characterization,
risk communication, risk management, and policy relating to risk.
Successful risk assessment and management, as in occupational exposure limit
(OEL) criteria documentation and OEL setting, depends on a number of condi-
tions, which can be summarized as: legitimacy, transparency, scientific methods,
and reasonable values.
Legitimacy in the process is achieved by conforming to recognized principles
and accepted rules and standards including, in some cases, legislative procedures.
This includes governing via an unbiased organization and independent experts,
with no special interests.
The process will gain from transparency, i.e. documented and publically
available procedures and results. This includes publication of
– names and affiliations of experts,
– criteria and work-procedures used,
– criteria documents,
– conclusions.
By a scientific approach is meant that the best available scientific data are retrie-
ved and critically evaluated. The conclusions should follow from the scientific
data in a way that is easy to understand, and references should be given to all
referred data. The scientific data are preferentially taken from the international,
scientific, peer-reviewed literature. Peer-reviewed and easy-to-access reports
enhance the possibility for critical examination by external reviewers and, thus,
also enhances transparency and legitimacy.
The above prerequisites contribute to credibility, which is essential to success-
ful risk management. Another element that is important and should follow from
the prerequisites is that reasonable standards are set.
Acute and chronic toxicity
Acute exposure has short duration. In toxicity testing, typically an oral dose is
administered to rodents at a single dose or repeatedly for a few days. Inhalation
3exposure is typically carried out for a few hours or repeatedly 6-8 hours daily for a
few days.
Chronic exposure has a much longer duration. Typically, as in many cancer
tests, chronic exposure of rodents is daily or 5 days/week for 2-years, correspon-
ding to nearly life-long exposure. Intermediate exposures are sometimes termed
subacute or subchronic.
Acute effects occur or develop during or shortly after short exposures (hours-
days). Acute effects may range from clearly reversible (such as mucosal irritation)
to clearly irreversible (such as death).
Chronic effects occur or develop after prolonged exposure (months-years) or
persist or develop further after exposure has ceased (as with cancer).
Toxicokinetics and toxicodynamics
Toxicokinetics is the quantitative description of the behaviour of a xenobiotic in
the organism. A common way to describe the kinetics is by concentration-time
curves and half-times for the substance itself or its metabolites in blood, plasma,
urine etc. The toxicokinetics may be divided into different types of processes:
absorption (uptake), distribution, biotransformation (metabolism), and excretion.
The acronym ADME (Absorption, Distribution, Metabolism, Excretion) is often
used for these processes. The term elimination may include excretion as well as
biotransformation.
Toxicodynamics refers to the relation between amount or level of the xenobiotic
at the target site and any effect from, for example, receptor binding to disease.
The toxicokinetics and -dynamic processes may be described as a chain of
relations from external exposure over target dose to adverse effect and disease
(Figure 1).
Dose concepts
Dose is the amount of xenobiotic that enters the organism. For substances that are
deliberately administered, such as pharmaceutical drugs that are injected or taken
as tablets or in animal toxicity testing where the test substance is given by gavage,
the dose is easily defined. For exposure at the workplace the dose may be more
difficult to define. Common alternative ways to describe the dose are: external
dose, absorbed dose, target dose and body burden (see also Figure 1).
External dose is often used as a dose surrogate for air pollutants. It is the
product of the duration of exposure and the average concentration in air during
that time. Expressed in a more mathematical way, external dose is the time
integral of the concentration in air. The true dose is thought to correlate with the
external dose under standardized conditions. However, the relation between
external and true dose depends on a number of factors, for instance the physical
activity during exposure (affects pulmonary ventilation and thus amount inhaled
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Figure 1. The chain of relations between external exposure, target dose and adverse
effect.
per time unit) and the affinity of the substance to tissues (affects the fraction of the
inhaled amount that is absorbed).
Absorbed dose usually refers to the amount of substance that reaches the
systemic blood circulation. In many cases absorbed dose is equal to administered
dose, that is, the bioavailability is 100%. However, for substances taken orally
the bioavailability may be substantially lower than 1 if the substance is e.g. acid
labile, metabolised by the microbial flora in the gastro-intestinal tract, or only
slowly penetrating the gastro-intestinal wall. The systemic bioavailability may
also be reduced due to so-called first-pass metabolism. In this case the substance
is absorbed through the gastro-intestinal wall and then follows the portal system
to the liver where it is metabolised to a large extent before it reaches the systemic
circulation (see also Figure 1).
Target dose is the amount of substance that reaches the specific tissue or cell
target. Target dose may also designate the maximum concentration near the target
or the product of time and concentration, i.e. the time integral of concentration
(often called AUC, area under the concentration-time curve). It is difficult to
measure the target dose. However, there is often a close relationship between
target concentration and blood or plasma concentration. Therefore the two latter,
or their AUCs, are commonly used as surrogates for target dose (see also Figure
1).
Body burden is the amount of substance present in the body at a given time.
Immediately after a bolus dose, such as an intravenous injection, the body burden
is equal to the dose. During continuous or repeated exposure, the dose increases
with time, whereas the body burden will eventually approach a plateau (steady-
state) level where the dose rate is equal to the elimination rate.
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Figure 2. Dose-effect relationship.
Haber’s rule
Haber’s rule states that the toxic response is related to the inhaled concentration
of a chemical multiplied by time of exposure. For other routes of exposure, such
as repeated oral administration, it states that the response is related to total dose.
This rule forms the basis of most OELs, which are usually expressed as 8-hour
time-weighted averages (TWA), corresponding to a normal working day.
Haber’s rule should be seen as a default approach and not a law, as there are
numerous well-known exceptions and limitations. The rule is obviously not
applicable to very rapid effects, such as irritation. Further, there is an upper limit
in time, which is different for different substances and effects (minutes for irrita-
tion, years for PCB).
Dose-effect and dose-response
The dose-effect relationship describes the relation between the dose and the seri-
ousness of a yes/no effect (Figure 2). It may also describe the relation between the
dose and the magnitude of a specific effect, such as elevation of blood pressure
or rating of eye irritation. The critical effect is the adverse health effect that first
appears at increasing doses. This is usually the least serious effect. The term
critical reflects that this effect, and the level at which it is first seen, determines
a critical limit. Below this limit no adverse effect are expected to occur.
The dose-response relationship describes the relationship between dose and
number of individuals affected by a specific effect. The number of individuals is
expressed as a fraction of the population, for example 0.32%, 3.2 per thousand
60%
100%
Dose / exposure level
Fraction of 
population 
affected
Figure 3. Dose-response relationship. As the response (fraction affected) approaches 0%,
it is increasingly difficult to estimate accurately.
workers, or 320 x 10-5 (Figure 3). The fraction may also be seen as a risk for an
individual. This is, however, misleading since the value only reflects the average
risk for all individuals. In reality, depending on genetic and environmental factors,
some individuals are at higher risk than others.
The no observed adverse effect level (NOAEL) and/or the lowest observed
adverse effect level (LOAEL) are frequently used in the absence of more complete
dose-response data, or to extract key information from dose-response data. The
values of LOAEL and NOAEL depend on which effects are being measured, the
sensitivity of the measurement, the number of subjects or animals in the study,
and the dose and dose spacing used.
The NOAEL is the highest dose not shown to cause a specified adverse effect.
When applied on the critical effect it gives an idea of an upper limit of an expo-
sure that will not result in adverse effects. The NOAEL may therefore serve as the
starting point to derive health-based exposure limits. The LOAEL is the lowest
dose shown to cause an adverse effect. It may well be that an ever lower dose
(hitherto not tested) will also cause effects. Thus, on theoretical grounds, one
cannot rely only on a LOAEL to derive a safe limit.
One problem with both the NOAEL and the LOAEL is that their values depend
on the doses and the dose spacing used in the study. This is illustrated by horizon-
tal bars in Figure 4. A more serious problem is that the values of the NOAEL and
the LOAEL depend on the statistical power of the study. Thus, using a realistic
number of subjects or animals, it is only possible to detect effects that hit several
per cent of the study group. This is illustrated by vertical bars in Figure 4.
7Figure 4. The values of NOAEL and LOAEL in relation to the ”true” response level
depend on the dose spacing (illustrated by horizontal bars) and the confidence limits of
the measured effect (illustrated by vertical bars).
Extrapolations
Due to high costs and ethical considerations toxicity studies are usually carried
out in a small number of animals. Therefore, only relatively high responses (high
up at the dose-response curve) can be demonstrated. However, for humans the
response of interest is that at low doses. This response is not readily obtained from
direct observations. Different approaches for high to low dose extrapolation are
used for different effects. For direct acting carcinogens it is common to apply
linear extrapolation with no threshold. This usually means that the response (i.e.
the increase in cancer frequency over the background) at the lowest dose with
reliable data is extrapolated by a straight line to origin (zero response at zero
dose). For irritants (i.e. substances with mucosal irritation as critical effect) it is
though that there is a distinct threshold and a steep dose-response curve (small
variability in sensitivity in the population). Hence, the threshold can be estimated
fairly accurately from, or even be substituted by, the NOAEL.
Most knowledge on toxic effects is obtained from animal studies and the trans-
lation to humans requires some kind species extrapolation. A common default
approach is to translate the dose on an anthropometric basis, i.e. by correcting for
body weight (bw), body surface area (bw0.67), or overall metabolic capacity, which
has been shown to correlate to bw0.75. If special circumstances are known, for
example that the effect is mediated via a metabolite and that the metabolism
differs between the two species, or that the two species differ in the expression of
a particular effect, these circumstances are also incorporated in the species extra-
polation. Usually, no correction for species is needed when the dose is expressed
Dose / exposure level
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NOAEL
LOAEL
True response level
8as an exposure level in air, since pulmonary ventilation correlates with overall
metabolism.
A third type of extrapolation is that between different routes of exposure. Since
many rodent studies are carried out by gavage, the most common route extrapola-
tion is from oral administration (in rodents) to inhalation exposure (of humans).
Two major complicating issues in route extrapolation are that the effects may be
related to local exposure, such as irritation of the respiratory tract, and, in the case
of systemic effects, that the degree and pattern of first-pass metabolism may differ
widely between the routes of entry.
Assessment factors
An assessment factor is a formal, arbitrary number with which one divides a
NOAEL or LOAEL to finally obtain an OEL or other limit value. The term may
allude to the final overall factor as well as subfactors that cover different aspects.
Other names commonly used are safety factor and uncertainty factor. The term
assessment factor is preferred since it emphasises that the choice of a particular
numerical value is performed within the risk assessment procedure, and that safety
as well as uncertainty issues are involved. The sizes of different subfactors depend
on the severity of effect (a safety aspect), the quality of the toxicological data
including the need for extrapolations (an uncertainty aspect), and how one chooses
to account for the (unknown) variability in sensitivity in the population (uncert-
ainty and safety aspects). The subfactors are commonly multiplied so that, for
example, factors of 10 for severity, 5 for extrapolation from oral to inhalation,
2 for extrapolation from rodent data to man, and 2 to account for population
variability, yields an overall assessment factor of 10 x 5 x 2 x 2 = 200. By this
procedure, even relatively small subfactors may result in an overall factor that
seems unrealistically high, judging by general toxicological experience. The rules
for use of assessment factors are often vague or arbitrary. As a consequence
different risk assessors will apply these factors differently. It is therefore impor-
tant that the numerical values of the factors and their rationales are clearly
documented for each substance.
Combined effects
By additive effects one means that the effects of a combined exposure is the sum
of the individual effects of the chemicals. An additive interaction is likely when
two or several substances have the same mode of action, such as for example the
narcotic effect of many organic solvents. If additivity prevails, and assuming that
two substances A and B are equipotent, the effect caused by combined exposure
to 2 ppm of A and 3 ppm of B will be the same as that caused by exposure to 5
ppm A only or 5 ppm B only. The interpretation and application of additivity may
be complicated by two factors, namely that the substances may have different
9potency and that the dose-effect curve is non-linear so that doubling the dose
gives more (or less) than doubling of the effect. If the combined effect is higher
and lower than expected from additivity the effect is said to be synergistic, and
antagonistic, respectively.
A hygienic effect can be calculated for mixed exposure to air pollutants, pro-
vided that additivity can be assumed. The hygienic effect is the sum of exposure
levels of individual substances, weighted in relation to their individual OELs. The
calculation is performed as:
Hygienic effect = ...
OEL
Conc
OEL
Conc
OEL
Conc
3
3
2
2
1
1 +++
Thus, under exposure to a single substance, a hygienic effect of 1 corresponds to
exposure at the OEL. More information about hygienic effect may be found in the
Swedish provisions on OELs and measures against air contaminants, available at
http://www.av.se/english/legislation/afs/eng0003.pdf.
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Criteria documents as a basis for OELs
Per Lundberg, retired, former chairman of the Nordic Expert Group, National
Institute for Working Life, Stockholm, Sweden, e-mail: per@kol.su.se
Introduction
What is a criteria document? According to an English dictionary, a document is
“an original or official paper relied on as the basis, proof, or support of some-
thing”. A criterion is defined as “a standard on which a judgement or decision
may be based”. From these definitions it is quite clear that a criteria document is
good basis for the decision of an occupational exposure limit (OEL). A criteria
document may also be looked upon as a review paper, especially prepared for the
purpose of setting an OEL.
Then, what should an ideal criteria document contain? It should contain a
complete, but concise, review of all relevant data. The best available published
information is the prime requirement. The most important data are the toxico-
logical data, but also data on kinetics, exposure and uptake must be included. A
table of contents for a document may contain the following headings:
– Identity
– Chemical and physical data
– Analytical methods
– Occurrence
– Toxicokinetics
– Toxicological data (including several subheadings)
– Mutagenicity, carcinogenicity, reproductive toxicity, immunotoxicity
– Dose-response/dose-effect relationship
– Summary and conclusions
– References
The desirable content of these chapters will shortly be described below.
Contents of criteria document
Identity
The identity of the substance is preferentially presented through the unique CAS
number. Also the chemically correct name should be given as well as the most
common synonyms, and internationally used trade names. The purity of the
substance in commercial products and common impurities may also be given in
this chapter.
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Chemical and physical data
In the chemical and physical data chapter the chemical formula (summary and
structure(s)), the aggregation state, form and colour are appropriate. Furthermore,
the melting point, boiling point, density (at 20°C), vapour pressure and solubility
(in water and/or other solvents) should be given. Odour threshold, octanol/water
partition coefficient and flash point are other data that could be appropriate.
Finally, the conversion factors ppm to mg/m3 (at 20°C and 101.3 kPa) should be
given.
Analytical methods
The title analytical methods is more or less self-evident and includes techniques
for sampling and analysing levels of a substance in air and in biological tissues.
The reliability of older methods should be discussed.
Occurrence
In the occurrence chapter a short overview of where in the working environment
the substance may occur. Available quantitative or semi-quantitative data should
be given with a clear distinction between personal exposure and background
workplace exposure. Available data on biological monitoring could also be
included in this chapter but would probably be better in the kinetics chapter.
Normally there is no need to give data on production and use (as they are not
relevant for setting OELs).
Toxicokinetics
The toxicokinetics chapter should contain data on the ways a substance is absor-
bed, distributed, biotransformed and excreted in the body. The absorption rate
should be given quantitatively, if possible. All absorption routes (pulmonary,
dermal, intestinal) should be described. The distribution part of the chapter should
discuss the transport of the substance or its metabolite(s) to organ and tissues. The
mechanism of biotransformation and metabolites formed should be presented.
Variations in biotransformation due to species differences or genetic factors may
be at hand. The excretion (or elimination) of the substance and/or its metabolites
should be covered. Biological half-time could have been measured or calculated
from kinetic models, and should then be included.
Toxicological data
The toxicological data chapter is the most important part of the criteria document
as it provides the key information on which an OEL should be based. The studies
should be exhaustively written and the data should be critically discussed,
especially when they may have relevance for the OEL. Primary sources should
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preferentially be used but high quality criteria documents or reviews from others
may also be used.
As mentioned above several subheadings may be used in the toxicological
chapter. First, it is reasonable to separate human data and animal data. Second,
one may divide the human or the animal data by organs that are affected. Third,
among animal data especially, it may be rational to differentiate between single
dose, short-term and long-term exposure.
The human data consist mainly of four different types; controlled experimental
data, epidemiological data, clinical data and case reports. In controlled experi-
mental data (often voluntary young male persons) the exposure usually is well
defined, and an effect exposure relationship may be at hand. In epidemiological
studies the exposure levels are not so well defined (mixed exposure is common).
These data, however, must be validated very critically as the may be affected by
confounding factors etc. ”Negative” epidemiological data should be given special
attention. Clinical studies and case reports may give support to other studies but
case studies should generally be taken as a memento of possible effects.
Animal data are more clear-cut than human data. It should, however, be pointed
out if they are established according to good laboratory practise (GLP) or not.
Numerical data should be given as mean values and range and/or standard devia-
tion should be presented.
Mutagenicity, carcinogenicity, reproductive toxicity and immunotoxicity
In the part dealing with mutagenicity both in vitro and in vivo data should be
given covering different endpoints. Carcinogenicity data should be divided, as for
other toxicological data, between animal data and human data. Full details should
be given, and the ”degree” of carcinogenicity could follow the IARC concept.
In the reproductive toxicology paragraph effects on male and female fertility,
embryo- and feototoxicity, and teratogenicity should be presented. The immuno-
toxicity part of the chapter should also include allergic sensitization.
Up to this point in the criteria document all available appropriate data should
have been presented and no new information should be given in the two last
paragraphs (dose-response and dose-effect or summary and conclusions). These
two paragraphs should further evaluate the data presented, and, if possible, a
critical effect should be given.
Dose-response/dose-effect relationship
In the dose-response/dose-effect relationship, data from the different studies
presented should be given in a table starting with the lowest exposure level. If the
data base is huge different tables for different types of studies (human–animal;
short-term–long-term etc.) could be used.
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Summary and conclusions
In the final chapter, summary and conclusions, a short and precise summary
should be given of the critical studies and effects. Comments on combination
effects and on susceptible individuals would be appropriate here. From the dose-
response/dose-effect relationship the lowest exposure level giving effect (lowest
observed adverse effect level, LOAEL) or highest exposure level without any
effects (no observed adverse effect level, NOAEL) should be pointed out. The
critical effect; the effect seen at the lowest exposure level should be given. Special
comments on dermal absorption, carcinogenicity and reproductive effects should
also be included in this chapter.
References
The references should be given in a proper way. References to unpublished paper
and to personal comments should be avoided.
Concluding remarks
Only for few substances there exist data to every heading. For some more substan-
ces the data base is not complete but sufficient as a background for the decision of
an OEL. In other cases it would be appropriate to mention the lack of studies/data.
Gaps in knowledge that are expected to have an impact on the critical effect
should be presented.
A draft criteria document could be written by a single scientist experienced in
toxicology or by a group of scientists. There exist good ”instructions to a docu-
ment author” and/or guidance on how to write criteria document. The draft should
then be discussed within a group of experts. It is of great importance that the
experts chosen do not have a direct relationship to industry. Representatives from
the employers and employees central organisations may attend the expert group
meeting as observers.
The expert group may be of ad hoc type or a standing committee. In an ad hoc
committee the members are chosen to each meeting depending on their expertise
about the substance(s) to be discussed. In a standing committee the evaluations are
more similarly for different substances thereby keeping continuity in the
decisions.
In some cases the committee itself proposes a numerical OEL value. They are
then using different kinds of extrapolation models, not always explained. In my
opinion this is not a scientific issue and the numerical value should be decided on
a governmental level, especially when the OELs have a legal status. A criteria
document which is well drafted and discussed scientifically in a committee to
reach a consensus about the conclusions is the best possible background for the
decision makers in setting an OEL.
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Information retrieval
Inga Jakobson, National Institute for Working Life, Library, Stockholm, Sweden,
www.niwl.se, e-mail: Inga.Jakobson@arbetslivsinstitutet.se
Introduction
In this paper, the subject of information retrieval from databases in occupational
toxicology is treated. General principles about searching for scientific literature
are described and a couple of databases with information on occupational toxi-
cology, biomedicine and chemistry will be presented. The paper is based on
experiences from literature searching for the occupational exposure limits criteria
work at the Swedish National Institute for Working Life.
General principles in literature searching
Databases
Availability. Modern computerized databases, with a good interface between the
user and the system, are necessary prerequisites for a successful search result. The
technical communication facilities thus must work and the vendor-customer
agreements be fulfilled, e.g. a valid customer identification code (user ID).
Databases with online access. International vendors are supplying different
kinds of databases, which are of great value for systematic searching in the
scientific literature in order to find ”good” references and to ”cover” a subject of
interest. Well developed and powerful search procedures, frequent upgrading and
updating, high quality with peer reviewed papers, fast access etc are advantageous
and such platforms usually give excellent results on toxicologic or chemical
questions. Direct access to the international databases (either online or via
Internet, see below) are thus of utmost importance for a successful outcome of
information for the criteria work.
Databases on CD-ROM. Many scientific databases are also available on CD-
ROMs and may be inexpensive alternatives for searching or they can serve as
complements to other electronic information systems.
Internet and the World Wide Web. Internet is growing extensively and is fre-
quently and increasingly used by different groups of information searchers. Most
of the scientific databases now are available over the web and the searching is
performed in a similar way as online or on CD-ROM. Often, you need a user ID
(see above) to get access to the data, even if general information about the system
is available to all visitors of the specific web site.
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Internet also has platforms for searching by use of ”global” search engines (e.g.
Alta Vista), which often can be of value. However, in the case of literature
searching for scientific purposes, they should be used with caution, since there is
no quality control of the outcome.
Selection by discipline. Selection of a set of relevant databases should be done,
primarily by discipline (e.g. work environment, toxicology, medicine, chemistry
etc.). Up to 5-7 different databases is suggested as an appropriate number.
Selection by structure. Selection of databases can also be done by structure, i.e.
bibliographic databases, where each record is a literature reference, or factual
databases, where each record may give information on a specific chemical
substance. It is of value to combine different kinds of sources, e.g. you get a
summary of compiled physical, chemical and toxicologic information from a
factual database and find the original papers and the latest literature from
bibliographic databases.
Producers and vendors. The difference between the producer of a specific
database and the host or vendor, who makes the database available to customers,
should also be noticed. Different vendors have their own user interface; a specific
database can thus be accessed in several systems by different methods.
Terminology and searching aids
Search language etc. Once you have access to a set of databases of your choice
you need to know the terminology of each system. In command based systems a
couple of command words are used, for instance S (search), D (display), P (print)
etc. On the other hand, in menu based systems, questions are given by the system
and should be answered by the user. In Internet searching with search engines
such as Alta Vista you just write some relevant word(s) and the search is per-
formed over the web, resulting in outputs depending on how often the word(s)
occur together etc.
Boolean operators. In most of the relevant systems the Boolean logic operators
AND, OR, NOT can be used. The operator AND combines different concepts
and gives hits where two or more separate terms occur in the same record. The
operator OR renders search results, where all the records contain at least one of
the chosen terms. The operator OR thus widens a search task with alternative
words for ”the same” concept (e.g. neoplasms OR cancer). The operator NOT
excludes a certain term or set of hits and is often useful when you analyse the
search results. The Boolean operators must be written according to the rules of
each system, with small letters or capitals or either.
Truncation. The use of truncation symbols or wild cards, e.g. *, ?, $ etc, means
that different suffices or grammatical forms of a word are ”substituted” by the
sign and searched together, (e.g. toxic* instead of toxic OR toxicologic OR toxi-
city etc.). It is important to keep a specific part of the chosen word(s).
Keyword searching. Many databases use descriptive keywords; each record thus
has a couple of terms attached, which are searchable. In thesaurus-based systems
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the keywords follow a hierarchical structure of terms grouped together in main
categories. The important medical database Medline (see below) is indexed with
highly structured keywords, i.e. MeSH-terms (Medical subject headings).
CAS-numbers. The CAS registry numbers or chemical identification numbers of
chemical compounds, set by the Chemical Abstracts Service of the American
Chemical Society, are searchable in many of the databases of relevance here.
Search techniques
The use of a good strategy for searching with specific terms gives the most power-
ful possibilities for a satisfactory result with an appropriate number of references.
The strategy can always be refined and a new searching performed, hopefully
with an improved result. If there are few hits, you could try to broaden the search
by the use of alternative terms, e.g. specific keywords, truncation etc or choose
another database. If you get many hits, you can limit the numbers by further com-
bination of search terms, limitation as to the time period covered, only reviews,
only human data etc.
Some databases of value in occupational toxicology
A presentation of a set of databases that the author has used on a regular basis
in literature searching for the occupational exposure limits criteria work at the
Swedish National Institute for Working Life will now follow.
Bibliographic databases
Arbline1 is produced by the library of the National Institute for Working Life;
Arbline constitutes its public catalogue. At present, Arbline comprises about
65 000 records on work environment and other branches of working life. Many
scientific papers from Sweden and other countries are included as well as books,
conference publications, criteria documents etc. The references are indexed
according to the thesaurus of the library.
Arbline is available via Internet; unfortunately you cannot, at present, use the
CAS-numbers for search in this form of the database. You cannot borrow the
documents from abroad, but Arbline could still be useful as a reference tool, and
you may find the internationally published papers via local libraries.
Nioshtic is produced by the US National Institute for Occupational Safety and
Health (NIOSH). The version of Nioshtic used by us at present is the OSH-ROM
from SilverPlatter Information Ltd; Nioshtic is one of six different databases with
                                                 
1 The database Arbline has recently been remodelled and is now available at
http://www.arbetslivsinstitutet.se/biblioteket/english/default.asp. CAS registry number are now
searchable in Arbline. At present, Arbline comprises nearly 73 000 records; many of the new
records are linked to full text electronic sources.
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over one million records. Nioshtic and the updated database Nioshtic-2 are
available from several other vendors, too.
Toxline is produced by the US National Library of Medicine (NLM) and
contains literature on toxicologic and biologic effects of drugs and other
chemicals. Toxline is available from several vendors online and on Internet as
well as on CD-ROM (e.g. SilverPlatter Information Ltd). The database now
includes over one million records.
Medline and its Internet version PubMed, where searching is done for free, are
produced by NLM. Medline is the most distinguished database in biomedicine
with over 11 million records. The excellent index system (MeSH-terms) used in
Medline and related databases has already been mentioned. Medline is available
from several vendors online, via the Internet and on CD-ROM.
Chemical Abstracts is produced by the American Chemical Society. It is the
largest database on chemical information and includes over 18 million records.
Chemical Abstracts is made available by STN International (the Scientific and
Technical Information Network) as well as by several other vendors.
Factual databases
Cheminfo and Registry of Toxic Effects of Chemical Substances (RTECS) are two
important factual databases on chemical substances, available as CD-ROMs from
the Canadian Centre for Occupational Health and Safety (CCOHS).
Cheminfo is produced by CCOHS; the database summarizes occupational
health and safety information on over 1 300 chemicals of importance for work
environment. Cheminfo is also available on the Internet.
RTECS is compiled by NIOSH and comprises toxicologic information,
including exposure limits etc, for over 140 000 chemical substances. RTECS is
also available online and on the Internet.
Registry file is related to Chemical Abstracts; it is a factual database where
chemical structures, CAS-numbers etc can be found. Registry file covers about
32 million substance records.
Suggestions on search strategy in the exposure limits criteria work
When you begin a new task to summarize the biomedical information on a
specific chemical compound, you should first check the basic information from
a factual database, e.g. Cheminfo, RTECS etc. Try to find the relevant CAS-
number(s), which are of great value in further searching; you may find the correct
numbers in databases, handbooks or catalogues.
In the next step, you should search for reviews on the state-of-knowledge of the
subject, for instance by search in a specific database (Toxline or Nioshtic) for
criteria documents, reviews or summaries. Please, note that in some of the versi-
ons of Nioshtic, the CAS-numbers should be written without hyphens. At this
step, you may find some distinct keywords, MeSH-terms, alternative search terms,
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specific toxic effects etc, and another search in the same database as well as in
other available databases should be performed. In databases on work environment,
you could make combinations with search terms from toxicology. In a medical or
toxicologic database, you could instead include occupational or work related
terms etc. You should also try to widen the search, using the operator OR between
terms of similar meanings, and take advantage of the truncation possibilities. The
different search steps may be structured together, e.g.:
– 107-13-1 or acrylonitrile
– toxic* or adverse or poison*
– cancer* or carcinog* or tumour* or neoplas*
– epidemiolog* or cohort.
Further, in the next step, you should make combinations of different sets of hit,
using the operator AND (e.g. #1 and #2 and #3 and #4). Browse the references
and look for relevant terms that could be used, while still on session. If you find
new interesting references, you can easily exclude those, which already have been
printed (or downloaded) with the operator NOT. The references are preferably
printed with the abstracts, and the search strategy should also be printed.
After the search session, the references should be analysed; this is quickly done
because the input terms often are ”highlighted”. You could enter the system again
for an iterative search directly or later.
At last, the relevant original documents should be obtained via your library or
from electronic document suppliers etc. The reference lists, especially from the
latest published papers, are other important sources for references.
General summary and concluding remarks
In this paper, an introduction into information retrieval and a presentation of
some databases of value for the occupational exposure limits criteria work have
been treated. Factual databases give basic information on a specific chemical
substance that can be used for further searching in the large scientific databases
recommended. With this strategy you can easily learn about the accepted
knowledge on the chemical(s) of interest as well as find the latest scientific
information.
Finally, good routines for document delivery are another important matter.
Today, many electronic document systems offer automatic delivery of their
papers, if you have a subscription, but that topic will not be further dealt with
here.
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Abstract
The objective of setting occupational exposure limits (OELs) in the European
Union (EU) was introduced into EU legislation some 20 years ago. In 1991, the
first set of 27 indicative limit values (ILVs) was proposed by the European
Commission (EC). At about the same time, the EC assembled a group of inde-
pendent scientists concerned with the derivation of OELs. In 1995, the status of
this group was formalised into the Scientific Committee on Occupational
Exposure Limits (SCOEL).
The SCOEL plays a key role in setting OELs in the EU. This committee
recommends to the EC “health-based” or “pragmatic” OELs. “Health-based”
OELs are recommended for chemicals for which a threshold dose for adverse
effects can be identified, and “pragmatic” OELs for chemicals for which such a
threshold dose is assumed not to exist. Special attention is paid to the way in
which the SCOEL evaluates carcinogens.
A separate committee, the Advisory Committee for Safety, Hygiene, and Health
at Work (ACSHH), consisting of representatives from governments, employers’
organisations and trade unions, evaluates the feasibility of the introduction of
OELs recommended by the SCOEL. This committee recommends operational
OELs to the EC that ultimately sets and promulgates ILVs or binding limit values.
ILVs are set for chemicals with “health-based” OELs that are considered not
to entail feasibility problems. Binding limit values are set for chemicals with
“pragmatic” OELs as well as for chemicals with “health-based” OELs that, for
the time being, are considered unfeasible at the workplace.
A personal view is presented on the use of deficient databases by the SCOEL,
and on some aspects of the working-methods and membership of the SCOEL.
Introduction
Occupational exposure limits (OELs) have been a rather common feature of the
industrialised world for the past 50 years or so (3, 12). They were introduced
at a time when the benefits of preventing occupational ill health (as opposed to
compensating its victims) were beginning to be appreciated, and analytical
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methodology had advanced to a state in which it was possible to measure the level
of contaminating substances in the workplace atmosphere (3).
The objective of setting OELs in the European Union (EU) was introduced into
EU legislation by Council Directive 80/1107/EEC, later on amended by Council
Directive 88/642/EEC, dealing with the protection of workers from risks related
to exposure to chemical, physical and biological agents at work (3). Under this
Directive, two types of OELs were defined, binding limit values and indicative
limit values (ILVs). In 1991, the first set of 27 ILVs was proposed by the
European Commission (EC) and agreed by Member States on the basis of pre-
existing national positions. At about the same time, the Commission assembled an
advisory group of independent experts in the various disciplines concerned with
the scientific issues related to the derivation of OELs. This group of scientists
from the various Member States began its work in 1990. In 1995, the status of this
group has been formalised by its maturation into the Scientific Committee on
Occupational Exposure Limits (SCOEL) via Commission Decision 95/320/EC. In
1998, the importance of setting OELs in the EU was underlined by the adoption
by the Council of Directive 98/24/EC, dealing with the protection of the health
and safety of workers from risks related to chemical agents and defining the role
and legal status of exposure limits (3).
The major task of the SCOEL is to study all available relevant scientific docu-
mentation on the toxicological and other relevant properties of chemicals, and to
recommend to the EC substance-specific OELs. A crucial aspect of the OELs
recommended by SCOEL is that they are based on toxicological and other health
sciences-related data and considerations only. Next, technical and socio-economic
feasibility aspects of the OELs recommended by SCOEL are discussed in a
separate committee, the Advisory Committee for Safety, Hygiene, and Health at
Work (ACSHH).
The present paper describes the general procedure for setting OELs in the EU,
with emphasis on the role and the activities of the SCOEL. Special attention is
paid to the way in which the SCOEL evaluates carcinogens. A personal view
is given on aspects such as incomplete databases, intra- and inter-committee
inconsistencies, consensus about committee decisions for instance on limit values,
advantages of a permanent (versus an occasional) committee, and selection of
committee members.
Objectives and uses of OELs
The objective of establishing OELs is to set limits for exposure to chemicals via
the airborne route such that exposure, even when repeated on a regular basis
throughout a working life, will not lead to adverse health effects in exposed
workers and/or their progeny at any time, as far as can be predicted from the
contemporary state of knowledge. Generally, the OELs recommended by SCOEL
represent the highest exposures which are regarded by SCOEL to be consistent
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with the above health criteria (3). However, in some cases it is not possible
to recommend an OEL that meets these health criteria. Therefore, SCOEL
distinguishes two categories of OELs: “health-based” and “pragmatic” OELs.
“Health-based” OELs are established in those cases where a review of the
available scientific data leads to the conclusion that a clear threshold dose can be
identified below which exposure to the chemical in question is not expected to
result in adverse health effects. “Health-based” OELs will ultimately lead to the
promulgation of ILVs by the Commission, provided no feasibility problems are
expected at the workplace. When for the time being the introduction of a “health-
based” OEL entails feasibility problems, the EC will set and promulgate a binding
limit value. “Pragmatic” OELs are established in cases where it must be assumed
that any level of exposure to the chemical in question, though small, might carry
some finite risk. Examples of properties for which it may not be possible on the
basis of current knowledge to define a threshold of activity are mutagenicity,
genotoxic carcinogenicity and respiratory sensitization. For chemicals possessing
such properties, ultimately binding limit values will be set that are considered to
carry an accepted (low) level of risk (3, 8).
When setting OELs, Member States should take ILVs into account but they are
not legally bound to set the same limit values. With respect to binding limit
values, Member States are legally bound to include them in their own legislative
regulations concerning exposure to chemicals at work.
The principal intended use of OELs is to provide standards or criteria against
which measured exposure levels in workplaces may be compared in order to
ensure that actual exposures are low enough and control is adequate to protect
health. OELs may also be used for design purposes, to ensure that new plants and
processes are engineered in such a way that exposures can be controlled at levels
which will not damage health. They should not be used as a basis for assessing the
acceptability of non-occupational exposure or for simplistically comparing the
toxicity of one substance with that of another one (3). Correct and appropriate use
of OELs in practice requires expertise and experience, particularly in situations
where there is exposure to more than one substance, where routes of exposure
other than inhalation may be significant or where working patterns are non-
standard (3).
General procedure for setting OELs in the European Union
Scientific Committee on Occupational Exposure Limits (SCOEL)
General approach
The SCOEL has adopted a “case by case” approach to the setting of OELs,
considering each substance individually. The SCOEL recommends to the EC
either “health-based” or “pragmatic” OELs. Such recommendations are based on
reviewing all available toxicological data and data on other relevant properties of
the chemical in question. Key elements of such a review are:
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– adequacy of the data base,
– establishment of the (nature and severity of) adverse effect(s) critical for
deriving the OEL. Are the critical effects local or systemic? Are they
caused by parent molecules or by metabolites? Are data available on the
mechanism and kinetics of absorption, distribution, metabolism and
excretion? Are they well characterised and well understood in terms of
extrapolation from animals to man or are they rather unusual? ,
– identification of the relevant study characterising the key effect(s) and
judgement of the quality of the key studies. To which extent is there
qualitative and quantitative agreement between different animal studies or
between findings in animals and humans? Are particular groups of people
likely to be at special risk?,
– establishment of whether the chemical acts via a non-threshold or a
threshold mechanism,
– assessment of the dose-response relationship for the key effect(s) including
the “no-observed-adverse-effect-level” (NOAEL) or “lowest-observed-
adverse-effect-level” (LOAEL) for chemicals for which a threshold
mechanism of action is assumed,
– setting an 8-hour time weighted average (8 hour TWA) OEL for “health-
based” OELs (see also the section on preferred values),
– calculating the cancer risk at specific exposure levels for non-threshold
genotoxic carcinogens (see also the section on carcinogens and mutagens),
– establishment of a “short-term exposure limit” (STEL) if needed,
– assignment of a skin notation if deemed necessary, and
– finally documentation of the entire process. For each individual OEL the
rationale will be set out in sufficient detail for the logic to be understood
by other professionals in the field, taking especially note of the choice of
the size the uncertainty factor (3).
Since a draft of the final (summary) document is made publicly available, the final
summary document incorporates public comments if considered relevant. Finally,
the definite summary document is published by the Office for Publications of the
European Communities (OPOCE) in Luxembourg.
For details on the criteria the SCOEL applies in carrying out its task, in
particular with regard to establishing the relationship between exposure level and
health effects, the reader is referred to EC (3).
Preferred value system
As a general rule, for recommendations of “health-based” 8 hour TWA OELs,
SCOEL will use preferred values, implying that OELs will be rounded up or
down to decimals of the integers 1, 2 or 5 ppm or mg/m3 for instance 0.05,
0.1, 0.2, 0.5, 1, 2, 5, 10 or 50 ppm or mg/m3 etc. SCOEL believes that further
discrimination, resulting in proposals falling in-between any two of these integers
or their decimals, would suggest a precision that is unjustifiable in view of the
limitations of the data base for the vast majority of the substances discussed and
the uncertainties involved in toxicological extrapolations (3). However, the use of
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the preferred value approach is not undisputed. Occasionally, representatives from
industry have criticized its use, arguing that preferred values have no scientific
basis and may lead to toxicologically unnecessarily low values. Indeed, the Dutch
Expert Committee on Occupational Standards does not use this system (10),
whereas some other committees on setting OELs such as the German “MAK
Kommission” (Senatskommission zur Prüfung gesundheitschädlicher Arbeits-
stoffe) and the international committee on Updating of Occupational Exposure
Limits do use the system (2, 5).
Carcinogens
For (most genotoxic) carcinogens for which, on the basis of current scientific
knowledge, it is not possible to identify levels of exposure below which there is
no cancer risk, SCOEL will estimate degrees of cancer risk at various exposure
levels, if the data base allows to do so. This will lead to the recommendation of a
“pragmatic” OEL and finally to a binding limit value.
In addition to recommending to the EC “pragmatic” OELs for such “non-
threshold” carcinogens, the SCOEL may also be requested by the EC to assist the
Commission in setting numerical limit values for such carcinogens by examining
existing scientific dossiers, examining and commenting on any proposals from the
Commission, and generally in advising the Commission in the light of the most
recent state of occupational medical and toxicological knowledge (3).
For (non-genotoxic and indirectly acting genotoxic) carcinogens for which it
might be possible to identify a threshold of activity, the SCOEL will recommend
“health-based” OELs, provided adequate data are available. For these “threshold”
carcinogens, OELs are derived, using the procedure for non-genotoxic/non-
carcinogenic chemicals, and, thus, are primarily based on NOAELs or LOAELs
for the relevant adverse effect (3). For this category of carcinogens eventually
ILVs may be established (8).
Advisory Committee for Safety, Hygiene, and Health at Work (ACSHH)
The ACSHH, the so-called Tripartite Committee, discusses and evaluates the
technical, social and economical feasibility of the introduction of OELs recom-
mended by SCOEL. This committee consists altogether of six representatives,
two each from governments of Member States, employers’ organisations, and
trade unions. The ACSHH recommends OELs to the European Commission that
ultimately sets and promulgates the ILVs or binding limit values (8).
Incomplete databases
It is not exceptional that the available toxicological database for a widely pro-
duced chemical or even for a high-production-volume chemical is incomplete.
Nevertheless, experts may decide to recommend an OEL, using their expertise
and experience and applying a relatively large uncertainty factor to compensate
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for the lack of information. In other cases, the experts may regard the database as
being too poor to justify the recommendation of an OEL. Although the kind of
deficiency may vary widely, in my view conspicuous and serious deficiencies are
the absence of repeated-exposure inhalation and reproduction toxicity studies.
With respect to the lack of inhalation toxicity studies, route-to route extrapola-
tion e.g. using the data from oral toxicity studies, cannot always be applied, for
instance when the critical effect of a chemical in all likelihood is local irritation.
Moreover, route-to-route extrapolation should be regarded as a necessary evil
anyway.
The definition of OEL includes protection of workers’ progeny (3). However,
although reproduction toxicity studies are lacking, often OELs are recommended
and finally ILVs or binding limit values are set. This is in my view a serious
shortcoming of the entire procedure unless the available toxicological data make it
most unlikely that effects on reproduction will occur at the recommended OEL.
The seriousness of the lack of data from reproduction studies is known for a long
time. Koëter (6) examined the data bases of 37 chemicals and found that for 35%
of the compounds parameters related to fertility and reproduction were more
sensitive than those measured in adequate subchronic toxicity studies. Obviously,
fertility and reproduction appear to be sensitive parameters that should be
included in toxicity testing at a relatively early stage (7).
Inconsistencies
Inconsistencies in the way OELs are derived within a committee such as SCOEL
may creep in and differences between committees in OEL values for the same
compound and based on a very similar database do occur. Clearly, the setting of
“health-based” or “pragmatic” OELs should be as consistent as possible but
consistency in my view should not be a “goal in itself”. There is little consensus
about the way to achieve consistency (4). There is some support for a uniform
system for the evaluation of substances: a classification by type of effects and
types of studies, and using more or less fixed correction, extrapolation and
uncertainty factors (1, 9). The weakness of such a system is that it may not be
used as a supplement to, but at the expense of the input of expertise and experi-
ence. Hundreds of evaluations conducted over the years have shown that expertise
and experience in various disciplines (and sub-disciplines to be called up if
necessary) thrown together within groups of dedicated experts are indispensable
for proper evaluations (4). Databases differ both qualitatively and quantitatively,
are often far from complete, and contain studies that vary widely in their rele-
vancy and adequacy. The consultative process nearly always involves intense
discussion on matters such as the toxicological relevance of certain effects, the
overall “no-observed-adverse-effect-level” and the size of the uncertainty factor
to be used. It is my conviction that fixed factors for all kinds of (theoretical)
situations are not very helpful and cannot guarantee objectivity. In my view, OELs
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should be based on reliable and relevant data evaluated by groups of competent,
experienced and dedicated individuals with expertise in different disciplines (4,
11). When this leads to inconsistencies within or between committees, so be it.
Consensus on committee decisions
As mentioned above, the key elements of a committee like the SCOEL are
experienced individuals with expertise in different relevant areas, discussing the
available data on a personal basis with the intention to reach consensus. The
discussions may be trenchant and feelings may run high but consensus is nearly
always reached on the basis of convincing argumentation. To reach consensus
may take a couple of meetings, the “time-out periods” being used to collect
additional data or to consult other experts. The “time-out period” is a practical
way to avoid minority views, and to offer the opportunity to re-study reports and
papers. In my experience, an OEL is hardly ever recommended after a single
SCOEL meeting. All of a sudden a member may raise a question or touch upon an
aspect that so far has not or insufficiently been considered but which turns out to
be of major relevance. So, in my opinion, a “time-out period”, which is the rule
rather than the exception, is indeed extremely helpful among other things to avoid
minority views (4).
Advantages of a permanent committee and selection of its members
In my perception, there is quite a difference between permanent (standing) and
occasional (ad hoc) committees. Members of standing committees such as the
SCOEL gradually get to know each other, learn each others’ expertise and are
willing to accept each others’ peculiarities, all of which promotes mutual
confidence and a relaxed atmosphere. Such settings warrant openness and a
vulnerable attitude during the debate, leading to optimum results.
What type of individuals is needed in a committee such as the SCOEL? The
best one in each discipline but with (a) at least a feeling for and some experience
in risk assessment and standard setting, (b) the willingness to listen to their fellow
members’ scientific arguments and to look for consensus, and (c) the willingness,
time and opportunity to study documents and to attend the SCOEL meetings.
Thus, expertise, experience, dedication and opportunity (rather than social back-
ground and position) should be the major criteria for selecting the members of
such committees. When a member is not genuinely interested in doing a good
job, this is extremely disturbing and insulting to the other members, and also
irresponsible towards workers and the society in general. Thus, the selection of
committee members is a rather important issue (4).
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Concluding remarks
Standard-setting is time-consuming, and thus, a costly operation. Therefore, the
use by SCOEL of criteria documents and other relevant reports available in
Member States should be encouraged, and co-operation with the Existing
Chemicals Programme should be streamlined and intensified. Indeed, for the
risk assessment of occupational exposure the SCOEL should be involved in this
Programme early on in the process. To achieve this the necessary skilled man-
power and pecuniary means should be made available to the responsible unit of
Directorate-General V in Luxembourg.
Since occupational standard setting in the EU has moved into an era in which
standards are expected to be supported by detailed toxicological evidence, more
complete databases and more workplace-oriented fundamental and applied
toxicological studies are warranted.
As a standing committee of independent scientists, the SCOEL plays a key role
in setting OELs. Therefore, the EC and the Member States should do their utmost
in looking for and finding qualified, dedicated members for the SCOEL.
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Abstract
In the Netherlands, occupational exposure limits (OELs) are established according
to a three-step procedure. In the first step, the Dutch Expert Committee on
Occupational Standards (DECOS) establishes a health-based recommended
(HBR)-OEL, using toxicological and other health sciences-related data and
considerations only. The HBR-OEL is finalised and published not until the draft
report (containing the recommended value for the HBR-OEL) has been made
public and sent to experts who are invited to comment. In the second step, the
Subcommittee on MAC (maximum accepted concentration) values (that consists
of representatives of employers’ organisations, trade unions and governmental
departments and which is a subcommittee of the Social Economical Council of the
Netherlands) evaluates the technical and social-economical feasibility of the
introduction of the limit values recommended by DECOS. The Subcommittee on
MAC values recommends operational MAC values to the Minister of Social
Affairs and Employment who, in the third (administrative) step, sets and promul-
gates the definitive MAC values that have force of law.
In addition to classification and labelling of carcinogenic substances, health-
based calculated occupational cancer risk values (HBC-OCRVs) are established
by DECOS for non-threshold (genotoxic) carcinogens.
Areas of attention highlighted in the present paper are discrimination between
sensory irritation and olfactory stimulation, desirability of dermal exposure limits,
and lack of reliable exposure data.
An international project (initiated by the Netherlands) that deals with the re-
evaluation of over 150 MAC values suspected of having no sound toxicological
basis and/or offering insufficient protection to workers, is briefly discussed.
Introduction
The first occupational exposure limits (OELs) were published in Germany in
1887. Since then lists of OELs have been issued in the USA and in several
European countries. The first list of threshold limit values (TLVs) of the
American Conference of Governmental Industrial Hygienists (ACGIH) appeared
in 1947. In the Netherlands, the ACGIH TLV list was used until 1978 when the
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Directorate-General of Labour of the Ministry of Social Affairs and Employment
(MSAE) published the first official list of maximum accepted concentrations
(MACs) which was largely similar to the ACGIH TLV list of 1977 (24). Since
1978, new MAC values have been established in the Netherlands according to a
three-step procedure, comprising a first health-based step, a second feasibility
step, and a final administrative step (24).
OELs may contribute a great deal to attaining and maintaining a good quality
working environment and, thus, to the health and well-being of people at work,
provided OELs are introduced and applied in a proper and realistic way by taking
into account possible implementation problems which may necessitate a stepwise
introduction (20).
Key elements of a procedure for setting OELs are toxicological data, a perma-
nent committee of experienced experts in various disciplines of health sciences, a
separate standing committee for the evaluation of technical and socio-economic
feasibility of limit values recommended by the health experts, indeed strict
separation of health and feasibility considerations, transparency of the whole
process, and, finally, OELs that have force of law (7).
The present paper briefly describes the Dutch three-step procedure for setting
MAC values, highlights the classification and hazard assessment of carcinogens,
and addresses some areas of concern such as the question whether the entire
procedure is too time consuming, the potential problem of confusing olfactory
stimulation and sensory irritation, and lack of proper exposure data. In addition,
an international project initiated by the Netherlands in 1997 that deals with the re-
evaluation of the health aspects of about 150 “old” MAC values suspected of
having no sound toxicological basis or offering insufficient protection to workers,
is briefly discussed.
The Dutch three-step procedure
Before describing the three-step procedure, it may be stressed that this procedure
is used for both carcinogenic and non-carcinogenic substances, and that in the first
step health-based limit values are recommended for all chemicals except for
subcategory Ia (genotoxic) carcinogens. For Ia carcinogens exposure-(tumour)
response relationships are established and cancer risk values are calculated (see
next section on carcinogens).
In the first step, the Dutch Expert Committee on Occupational Standards
(DECOS) establishes a health-based recommended (HBR)-OEL. DECOS is a
permanent committee of the Health Council of the Netherlands (HCN), one of the
major scientific advisory boards for the government. Under the responsibility of
DECOS, a criteria document is produced and published that contains data on the
toxicological and other relevant properties of chemicals, a critical evaluation of
these data and also the HBR-OEL. A draft of the criteria document, called the
Public draft document, is submitted for comments to experts from industry and
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trade unions, and in fact is available to experts world-wide. DECOS studies
all comments submitted and, if these are considered relevant, alters the draft
document accordingly. If the changes are significant, including a different value
for the HBR-OEL, the draft document goes public again. Finally, the criteria
document is published by the HCN. The two crucial aspects of this first step are:
the HBR-OEL is based on toxicological and other health sciences-related data and
considerations only, and the HBR-OEL is finalised and published not until the
draft criteria document has been made public to experts who are invited to
comment (6).
In the second step, the Subcommittee on MAC values, a permanent committee
of the Social Economical Council, discusses and evaluates the technical, social
and economical feasibility of the introduction of the HBR-OEL. This Subcom-
mittee consists of representatives of employers’ organisations, trade unions and
governmental departments. The Subcommittee recommends an operational MAC
to the MSAE. This recommendation, complete with argumentation, is publicly
available. A major aspect of this second step is that it shows whether the recom-
mended MAC value is identical to the HBR-OEL, and if not, the reason for the
difference (6, 8).
In the third step, the MSAE sets and promulgates the MAC values. Clearly, the
aim is to have all MAC values identical to the HBR-OELs, preferably right from
their introduction but if this is not feasible, then in the foreseeable future (6, 7, 8).
Carcinogens
Classification
Since 1978, in the Netherlands, carcinogens have been classified into two broad
categories viz. genotoxic (category I) and non-genotoxic (category II) carcinogens
(10, 15, 18). In 1996 (11), category I carcinogens have been divided into two sub-
categories, subcategory Ia and subcategory Ib. Subcategory Ia carcinogens act via
stochastic processes i.e. the carcinogens themselves or one of their metabolites
can bind directly to DNA, leading to an irreversible DNA modification, with the
implication that no threshold dose can be derived below which the carcinogen
would be expected not to induce cancer. Examples of such carcinogens are
vinyl chloride, benzo(a)pyrene and chromium VI compounds. Subcategory Ib
carcinogens can induce DNA damage via indirect processes such as for instance
inhibition of DNA repair enzymes or elevation of endogenous free-radicals, with
the implication that a threshold for genotoxicity, and thus, also for carcinogenicity
can be assumed. Examples of such carcinogens are arsenic, cadmium compounds
and crystalline silica (11, 17). Non-genotoxic (category II) or epigenetic carcino-
gens do not induce irreversible DNA modifications and act by a non-stochastic
mechanism such as for instance stimulation of cell growth or gene expression,
implying that for these carcinogens a threshold dose can be derived (11). In those
(exceptional) cases where the available data on carcinogenicity and mutagenicity
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do not allow classification, but a quantitative cancer risk assessment is neverthe-
less deemed desirable, precautionary such a substance is treated as if it were a
Ia carcinogen. An example is wood dust (12, 22). This classification system is
generally accepted in the Netherlands as the scientific basis for the regulation of
carcinogenic substances.
In addition to this system for the classification of carcinogens, the Netherlands
use a labelling system as required by the European Union (EU). This labelling
system uses standard phrases based on the above distinction between category I
(genotoxic) and category II (non-genotoxic) carcinogens. The standard phrases,
which are meant to be informative refinements of the EU classes, are presented in
Table 1.
Health-based calculated occupational cancer risk values (HBC-OCRVs) for
subcategory Ia genotoxic carcinogens
For genotoxic carcinogens without a threshold (subcategory Ia carcinogens) in the
Netherlands, the linear multistage, non-threshold model is used to extrapolate
linearly from the lowest dose showing excess tumours in animals or humans (11,
23). The rationale for extrapolating from the lowest dose is that at higher doses
Table 1. Standard phrases used for classification of carcinogens in the Netherlands.
Standard phrases Comparable
with EU class
This compound is known to be carcinogenic to humans 1
• it is a genotoxic carcinogen
• it is a non-genotoxic carcinogen
• its potential genotoxicity has been insufficiently investigated. Therefore, it is
   unclear whether it is a genotoxic carcinogen.
This compound should be regarded as carcinogenic to humans 2
• it is a genotoxic carcinogen
• it is a non-genotoxic carcinogen
• its potential genotoxicity has been insufficiently investigated. Therefore, it is
   unclear whether it is a genotoxic carcinogen.
3(A)This compound has been extensively investigated, but there is insufficient
evidence of a carcinogenic effect to warrant a classification as “known to be
carcinogenic to humans” or as “should be regarded as carcinogenic to humans”.
It is a suspected human carcinogen.
3(B)This compound has been insufficiently investigated. While the available data do
not warrant a classification as “known to be carcinogenic to humans” or as
“should be regarded as carcinogenic to humans”, they indicate that there is a
cause for concern. It is a suspected human carcinogen.
This compound cannot be classified. not
classifiable
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the shape of the dose-response curve could be affected by toxicity. Other extra-
polation models can be used for Ia carcinogens, if there are convincing data that
such a different approach is more appropriate (23). DECOS uses a standard
procedure for the derivation of the so-called health-based calculated occupational
cancer risk values (HBC-OCRVs) for subcategory Ia carcinogens (9). The major
elements of this procedure are selection of the key study, calculation of the
carcinogenic activity expressed as incidence per unit daily dose or per unit air
concentration (in principle using the linear, multistage, non-threshold extrapola-
tion model), and then calculation of the HBC-OCRV i.e. calculation of the
additional lifetime cancer risk in workers (= humans exposed at the workplace).
For this latter calculation DECOS assumes that humans weigh 75 kg, live 75
years, and inhale per day 18 m3 of air, and that workers are exposed 8 hours per
day, 5 days per week, 48 weeks per year for 40 years and inhale 10 m3 of air
during an 8-hour working day. Using the HBC-OCRV, DECOS finally calculates
air concentrations associated with two reference lifetime cancer risk levels for
workers viz. 4 x 10-3 (upper or ban level) and 4 x 10-5 (target level). These
reference cancer risk values for the workplace have been defined by the MSAE.
For details of the various calculations the reader is referred to HCN (9). It may be
emphasised that for establishing HBC-OCRVs the three-step procedure described
above is fully applied, including a public draft document and a criteria document
published by the Health Council, followed by the second feasibility step and
finally the third administrative step in which the Minister establishes a legally
binding occupational exposure limit.
Ordinary MAC values for subcategory Ib and category II carcinogens
For subcategory Ib and category II carcinogens (carcinogens for which a threshold
value can be established; see above) HBR-OELs and MAC values are established,
using the “No-observed-adverse-effect-level/Uncertainty factor” approach which
is also applied to non-carcinogens (9, 11).
Procedure too time consuming?
The complete procedure for setting a MAC value may take several years. Such a
long period of time is incompatible with concepts of speed, forcefulness, prompt-
ness and responsiveness (19). However, in my view carefulness and quality
should prevail in order to maintain the credibility of both the process and the
experts involved, and, most importantly, the credibility of the established MAC
values. Since there are always constraints of finance and the availability of
experienced and skilled manpower, fewer carefully established MAC values are to
be preferred over more MAC values of doubtful repute. Moreover, the relatively
long period between the publication of the (draft) HBR-OEL and the setting of the
legally binding MAC value gives industry the opportunity to think about or to take
already measures, if necessary, to meet the new (lower) value. When reliable
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exposure data clearly show that a (much) lower exposure limit than the one being
discussed by DECOS would not involve any technical or economic difficulty,
it has been suggested (5) that it would save time to stop the discussion and to
immediately recommend a low (exposure-based) OEL. In my view such a
pragmatic approach should not be pursued and DECOS should complete its
deliberations and recommend a health-based OEL. Of course in step two or three
of the procedure an exposure-based MAC value can be suggested or set without
compromising the process.
Olfactory stimulation not to be confused with sensory irritation
Both odour (olfactory stimulation) and sensory irritation (trigeminal nerve
stimulation) are chemosensory effects. They serve as warning signals and do not
lead to cell or tissue damage. An unknown odour is a warning signal to which we
do not have an appropriate response; it may cause uneasy arousal but odour
per se does not make us sick. A known odour very often does not lead to uneasy
arousal because we know the (absence of) consequences; this is so-called positive
bias. Sensory irritation is characterized by a burning sensation in the nose and
inhibition of respiration from that site; clearly it is an adverse effect. Since in the
literature a clear-cut distinction between odour and irritation is not always made,
this may be a source of confusion, in particular when we are confronted with an
irritant with a strong odour. At present a number of objective methods is available
to distinguish between sensory irritation and olfactory stimulation (1, 3). To be
able to make such a distinction is important for a correct interpretation of the
chemosensory effects of chemicals. For a correct interpretation of these effects it
is also crucial to understand the difference between adaptation and habituation.
Adaptation is the decrease in sensitivity to a prolonged stimulus; once adapted to a
certain stimulus there is no longer an effect of this stimulus; however, an adapted
status is to be considered an unwanted status. Habituation is the decrease in
responsiveness to a prolonged or repeated stimulus; this is an unconscious coping
behaviour which is subject to cognitive influences; the stimulus is still there but
since we are used to it and we know that it does not harm us, we do not notice it
anymore. In my experience, in studies on chemosensory effects both phenomena
are often mixed up which may lead to wrong conclusions. The major flaw is that
when adaptation is reported, it may in fact be habituation, which means that there
is no adaptive response (1, 4).
Dermal exposure limits
For workers, a major route of exposure is through the skin. However, no dermal
occupational exposure limits (DOELs) exist. What does exist is the so-called “skin
notation” which is a warning system against substantial absorption of a chemical
through the skin, implying that the MAC value of the chemical in question may
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not sufficiently protect the worker against its toxic effects. At the request of the
Dutch Ministry of Social Affairs and Employment, a concept has been developed
for setting health-based DOELs (2). A DOEL limits the amount of a chemical on
the skin, (external dermal exposure) and consequently limits the potential dermal
uptake of a chemical. The establishment of a DOEL is based on either the percen-
tage skin absorption (estimated for a specific dermal exposure area) or on skin
absorption rate (= the flux defined as the skin permeability constant multiplied
by the concentration gradient across the stratum corneum; in fact Fick’s first law
of diffusion). Recently, a Committee of the Health Council of the Netherlands
published a draft report dealing with the possibilities of regulating dermal
occupational exposure (16). In addition to the “skin notation” and the DOEL, the
Committee discusses the use of biological limit values (BLVs). A BLV limits the
total amount of a chemical taken up by the body, and thus is a limit value for the
total internal “toxic load” of that chemical. The Committee recommends to use
BLVs whenever possible, recognising that the data and methods of analysis
allowing the derivation of BLVs are often lacking. The Committee realizes that
this is often also true for the derivation of a DOEL, implying that the derivation of
a MAC value with “skin notation” is the only realistic alternative. Finally, the
Committee developed a four-step procedure to find out whether the assessment of
the health risk from dermal exposure to a specific chemical has high, medium or
low priority (16).
Lack of reliable exposure data
Without reliable data on exposure OELs cannot be used to characterize the
potential health risk of workers. Moreover, in the past deliberate and systematic
underreporting of occupational exposures has occurred with rather serious conse-
quences for the interpretation of epidemiological studies, using these flawed
exposure data, particularly in case of “positive” results. “The only problem in
human exposure assessment is the lack of knowledge and information” as stated
by Marquart et al. (21)! Very often data are lacking on the form and way in which
a substance is being used, rendering exposure assessment very difficult. Data on
(measured) exposure levels are often very limited or completely absent, indicating
the necessity to use models for exposure assessment. However, most models lack
validation, occasionally leading to outcomes which differ remarkably depending
on the model applied. Obviously, substantial efforts are needed to improve worker
exposure assessment. “Learning by doing” and “learning by example” are pro-
cesses that eventually will improve exposure assessment (21).
Health-based reassessment of MAC values
At the request of the MSAE, in 1995 TNO Nutrition and Food Research (Zeist,
the Netherlands) assessed the degree of health protection of the MAC values of
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almost 300 substances as published in the (Dutch) MAC list of 1994. Most of
these MAC values were borrowed from the ACGIH TLV list, and they were
suspected of having no sound toxicological basis or offering insufficient protec-
tion to workers (14). TNO concluded that for 109 substances the MAC value was
too high from a health protection point of view, with deviations ranging from a
factor of 2 to 250. For another 106 substances the toxicological data base was
judged to be too poor to justify the recommendation of a health-based OEL (13).
In 1997, the MSAE requested the HCN to re-evaluate these substances in a
condensed procedure and to recommend health-based OELs. The MSAE further
requested the HCN to invite scientists from outside the Netherlands to participate
in this re-evaluation project (13).
After consultation of several regulatory authorities of European countries, in
1997 the HCN formed an international committee (Committee on Updating of
Occupational Exposure Limits) of acknowledged experts in toxicology, epidemio-
logy or occupational medicine, with experience in setting OELs. The committee
consisted of 12 members from eight different countries, one corresponding
member, one advisor from the MSAE, one observer from the HCN, and one
scientific secretary of the HCN. All members were invited à titre personnel,
except for the corresponding member representing ACGIH. Except for some
minor details, the committee followed a procedure for establishing HBR-OELs
very similar to the first step of the Dutch three-step procedure for setting OELs
(see above), including the production of a public draft document and a final
criteria document published by the HCN. This criteria document will then be used
by the Subcommittee on MAC values to recommend an operational MAC value,
and finally the Minister will set a legally binding MAC value.
In the end, the MAC values of about 150 substances were re-assessed (13). In
August 2001, the final reports (criteria documents) for 17 substances have been
published; it is expected that the reports of the remaining substances will be
completed in the course of 2003.
Concluding remarks
Occupational standard-setting should be a continuing activity because OELs may
contribute a great deal to attaining and maintaining a good quality working
environment. Indeed employers and employees are guided by standards. Crucial
aspects of a procedure for setting OELs are transparency of the entire process
and strict separation of health and feasibility considerations. Moreover, OELs
should be legally binding. For those genotoxic carcinogens for which an exposure
level without any cancer risk is assumed not to exist, so-called non-threshold
carcinogens (subcategory Ia carcinogens), in the Netherlands lifetime cancer risk
values for workers are calculated, using a linear, multistage, non-threshold
extrapolation model. An international project initiated by the Netherlands in 1997
deals with the re-evaluation of the health basis of the MAC value of a substantial
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number of chemicals. These MAC values were suspected of having no sound
toxicological basis or offering insufficient protection to workers. Ultimately, the
MAC values of about 150 chemicals were re-assessed. For a considerable number
of these chemicals the data base was found to be too poor to justify the recom-
mendation of a health-based OEL or even to comment on the existing MAC value
in terms of (much) too high or about right.
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Occupational exposure limits in Sweden -
socioeconomic and technological aspects
Bertil Remaeus, Swedish Work Environment Authority, Sweden, www.av.se,
e-mail: bertil.remaeus@av.se
Introduction
Sometimes there is a thinking that the Nordic countries have the same system
preparing limit values. There is a Nordic way of looking upon the problem in
the field of Occupational Safety and Health, maybe also some similarities in the
systems preparing the occupational exposure limits (OELs), but there are also
differences in decision-making. What is described is the Swedish model as it has
worked in the past, and is working today. Which model that will be used in the
future, nobody knows.
Discussing OELs, and the way they are issued, demands that the legal ground
for the limit values is defined. It is not useful to compare different values if their
legal background differs from binding regulations to recommendations. For a
number of substances different countries have issued different values. One of the
reasons could be that the limit value in one country is mandatory but in another is
just a recommendation/guidance. This will, from natural reasons, have implica-
tions on the value decided.
There is also a need to describe, or be aware of, the ”environment” in which
the limit value is valid. The Swedish regulation on limit values is one part in a
system. That system, creating the Work Environment Policy, is based on a number
of cornerstones, like
– Strong political support of improving working conditions
– Strong frame-work oriented law
– Far-reaching delegation of power to the SWEA
– Strong and well-educated safety representatives
– High degree of unionisation, blue-and whitecollar
– Access to qualified research
– Good statistics on injuries and ill-health
– Qualified and effective supervision and control by the competent authorities
– Well-educated and, in an international comparison, progressive employers
This means that the regulations as such can interact with other intervention tolls,
in quite another way, compared to societies where those other parts are notas
active or, in some cases, maybe not even existing. So, the existing OELs in
Sweden must be looked on, having this background in mind.
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The legal base for the Swedish OEL setting.
The base in Sweden is the Work Environment Law and Ordinance. This act
draws up the frame for different actions taken by the Swedish Work Environment
Authority (SWEA).
One section in the act reads " the work environment shall improve due to the
social and technical development". In reality this means that even without any
change in the scientific data, the OEL could be lowered as a consequence of what
is said above.
In the act the SWEA is given the mandate to issue legally binding regulations
without taking the matter to the government whatever the costs for the society.
This reflects a political unanimous decision in the seventies when the act was
issued by the parliament and has been unchanged since that. The SWEA though
has to carry out a description of the consequences. I will not call it a cost-benefit
analysis. Even if it is possible to calculate the costs, the benefit is more difficult to
calculate. There is no tag available making it possible to calculate human damage
or suffering in economic terms at an individual level.
Within the frame of the Work Environment Act the ordinance on limit values
interacts with other regulations. So, you have to look upon them as a package
which should be enforced. Every single part in it is connected into a chain. The
way the Swedish regulations work together is illustrated in Figure 1.
This means that it is easier for the Labour Inspectorate, (L.I.),13/02/02 to use
coercive measures against an employer if monitoring shows that the actual level of
contaminants is above the limit values, but the L.I. has still the possibility to use
other regulations, for example the ordinance about measures against air
contaminants. As the OELs define the highest acceptable level, the L.I. has the
power to demand the employer to further reduce the level of exposure.
Work Environment Act
Exposure
Maximum allowable concentration/limit value (OEL)
Ordinance on
“Measures against air contaminants”
Figure 1.
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The competent authority, in Sweden the SWEA, has a number of actions to
choose when deciding how to tackle a work environment problem related to
airborne exposure. OELs is one method among others;
– Limit values
– Regulations/restrictions of the handling
– Substitution
– Banning
You can use either one or a combination of these tools. The Swedish asbestos
policy is probably the first example of what today is called the substitution
principle. The policy started with a limit value in the sixties, followed by different
regulations and restrictions of use in different branches and terminated by a total
banning in the beginning of the eighties. This can illustrate the principle of
decreasing the "collective dose". By issuing a limit value, and nothing else, you
decrease the exposure but not the number of exposed. By issuing also restrictions
of use in different branches, you also restrict the number of exposed which leads
to a lower "collective dose".
This method could always be challenged. How can the authorities accept expo-
sure in one branch, but not in another? This leads to further problems, the risk
with alternatives. Which impact will a low limit value have on the employers´
choice between different products? If a low limit value leads to a transition to
other substances without, or with a higher limit value, and those substances are
not investigated and there are no scientific data, what are the consequences? This
is a reality that all regulating authorities have to take into consideration. The
SWEA will not accept the thought of having different limit values in different
branches or at different companies. The base for the regulations must be scientific
data combined with social, technical and economic aspects. This leads to the
conclusion that if some companies can't comply with the regulations, they have to
take action. In the short term this could mean use of respirators, but normally not
in the long term. If they still can't comply with the OELs the final consequence
could be closing the activity down.
The asbestos case is also an example of the problem of monitoring effects of
different governmental interventions like limit values. The activities mentioned
above resulted in a dramatic decrease in the import of raw asbestos. The results
are visible from Figure 2. The effects on human health are harder to document.
There are at least three diseases recognized as related to asbestos exposure; lung-
cancer, mesothelioma and asbestosis. The number of reported cases of asbestosis
increased as a result of the exposure. With a latency period of maybe 20 years
from start of the exposure, the number of reported asbestosis cases had a maxi-
mum in the beginning of the eighties, while the reported number today is one or
two annually. Even in this case the effect of different activities in the seventies
pays off a decade or two later. In the case of mesotheliomas the situation is even
more difficult. Mesothelioma has a very strong relation with asbestos exposure,
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Figure 2. Number of imported raw asbestos in relation to number of cases with
mesothelioma and asbestosis.
but also a long latency-period, maybe 30 years and more. That means that the
result of interventions; regulatory, information, activities from the safety
representatives and decisions from the employers mainly in the construction sector
not to use asbestos, are not possible to monitor in Sweden until maybe 2005 and
later. As shown in Figure 2 the number of mesotheliomas reported have still not
decreased. In maybe 10 years from now it will be possible to monitor, by
comparison with countries which choose a more asbestos friendly policy in the
eighties, the real effect of the interventions decided in the seventies. This case
shows the need of having supplementary intervention tools to support and
strengthen the regulations on OEL. It also shows the problem of lack of metho-
dology to monitor effects of changes in the OELs or other governmental activities,
at least when it concerns substances with long latency periods.
The Swedish system of setting OEL
The system of setting OELs in Sweden is described in Figure 3, keeping in mind
what has been said above, about the OELs as one out of several tools available to
improve working conditions.
Up till 1992 the system was tripartite, even in decision-making. Since then the
employers have left the directorate of SWEA, leading to a decision in the govern-
ment to change the appointments in the directorate even for those representing the
employees. Today the board members represent the working life, without direct
representation of the social partners.
To support the staff of the SWEA in preparing proposals for new OELs the
social partners are invited to appoint representatives in the process preparing the
proposed OELs. When the staff of SWEA has enough data, the social partners are
invited to comment on the material. The work with the OELs goes on until the
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Figure 3. The system of setting OELs in Sweden.
available material has been commented on and analysed. One of the most
important tasks of the tripartite process is to support the SWEA-staff in choosing
those most prioritised substances to be sent to the Criteria-group, in order to ask
for a scientific report. Normally the capacity of that group limits the number of
substances to maybe 10 annually. The Criteria-group is a scientific-group, chaired
and administered by the National Institute of Working Life (NIWL).
The group and its work is the responsibility of NIWL. The scientists appointed
to this group are chosen by NIWL, like any other scientist appointed to carry out
work related to the writing of a criteria document. The SWEA has no role, other
than observer, in this activity. The expected, and wanted, outcome from the
Criteria-group is a consensus document, containing the scientific data about the
substance, and hopefully also targeting a critical effect and a dose-response/dos-
effect relationship. The Criteria group does not propose any OEL.
Together with other data the group takes into consideration the scientific report.
Based on the document, the group has to consider different values, considering
technical possibilities, social and economic consequences.
The final preparation of the proposals to the Board of SWEA, and eventual
corrections due to comments received in the public hearing, is a matter for the
staff of SWEA. At the same time the proposal is sent to the Board, an invitation
to participate in a new revision is sent out, and the work according to Figure 3
above starts again.
There are often questions whether the regulating authority deciding about a
limit value takes into account other data than the scientific about health effects.
The answer to that is, yes of course. If not, every limit value should be zero, as
Tripartite process chaired by SWEA-staff
Identification of substances
Priority Criteria group
Scientific reports
   Other data Exposure levels
Number of exposed
Evaluation of data
Discussion
Proposal    Public hearing
Correction
Decision of the board of SWEA
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that is the only definite level where you could guarantee that employees are not
injured. Which impact other facts have when it comes to the setting of the actual
value, is depending of the risk, or which is the critical effect. The higher the risk,
the lesser impact from economic or other factors.
Another way of handling such a problem is of course to use the date when the
limit value is entering into force as a modifier. If the date is adjusted in a way
meaning that the entering into force of the limit value is later than normal, it gives
the employers a better possibility to take measures. A similar way is to use the
proposed limit value as a "planning value" saying that this is something which
will come in a couple of years, or that the planning value is valid for new plants to
be built from a certain date.
If the OELs in different countries are compared you will very often find diffe-
rent values, even if the scientific base is the same. This could reflect a number of
decisions. One explanation, the simplest one, is that countries often revise their
OELs in cyclic periods. If you compare a just recently revised OEL with one in
a country which issued the OEL maybe ten years ago, of course this does not
necessarily show a difference in risk assessment, but simply a practical difference
of where the regulating authorities are in the work with revision of the values. On
the other hand it could reflect either the legal base for the OEL, where it is easier
to lower an OEL if it is just a recommendation, compared to a situation where it is
legally binding. It could also reflect a difference in the evaluation of the critical
effect. In some countries irritation for example is not accepted as a critical effect,
while others accept it, leading of course to different conclusions. One of the most
well-known example of such differences is the evaluation of the risks connected to
exposure to solvents, where specifically the Nordic countries have had one
approach to the problem, and many other countries have not accepted low level
exposure as a critical effect.
Conclusion
The Swedish system of OEL-setting has a long history of tripartism, which has
shown being successful. The OELs are based on scientific reports produced in the
“scientific world”, without influence from the staff of the competent authority.
The scientific report does not contain any proposals of values, but defines norm-
ally a critical effect and a dose-response/dose-effect relationship.
The proposed limit value is based on the criteria document and other relevant
available information, taken into account technical development and economic
factors. The higher the risk, the lesser consideration is given to economic factors.
The competent authority, SWEA, does not have to consult the government
before issuing the legally binding occupational limit values. The ordinance on
limit values is revised roughly every third year.
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Abstract
The American Conference of Governmental Industrial Hygienists (ACGIH) has
established and maintained a list of occupational exposure limits for use by
industrial health professionals in preventing work-related disease associated with
chemical exposures. Proper application of these exposure limits, the threshold
limit values (TLV) and biological exposure indices (BEI), requires a firm
understanding of the basis and procedure for their establishment, and of the
quantitative aspects of their implementation.
The TLV and BEI are set up by two expert committees who consider available
scientific data relating health risks to exposure. The process of developing expo-
sure limits is based heavily on evaluation of the peer-reviewed scientific literature
and is coupled with professional judgement. The TLV and BEI are reviewed
frequently, and adjustments are made rapidly where new data dictate.
Quantitative aspects of the TLV include the selection of proper averaging time,
the need to account for the presence of multiple compounds in a worker’s
environment, and for the presence of several sources of variation in exposure and
measurement. Less quantitative features of TLV implementation include the
presence of substances which may cause cancer or sensitization, and the overall
process of making decisions regarding the presence of health risk, based on
exposure measurements and comparison to the relevant TLV. Each of these issues
is reviewed in the presentation to follow.
Complementary to the TLV, the BEI represent the levels of the chemical agents
or their metabolites to be expected in the body fluids of workers with exposure
at the TLV. Their establishment imposes some additional requirements on the
available scientific data: these relate to the need for detailed information on the
biological fate of inhaled chemicals, and on the relationship between internal dose
and health risk. As examples, the BEI for lead, toluene, and methoxyethanol are
presented to illustrate their application and to explore the recommended interpre-
tation of the results of occupational biological monitoring.
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Introduction
General characteristics of occupational exposure limits
Standards and guidelines limiting exposure to chemical and physical agents in
industry have been established to prevent the development of the specific occupa-
tional diseases that could otherwise result from higher levels of exposure. A
further goal is to prevent their possible contribution to the onset, progression or
severity of chronic illnesses initiated by non-occupational agents. The degree of
protection to be provided must extend over the full span of a working career.
At present there are occupational exposure limits for over 700 compounds, out
of the 60 000 or more chemicals used in manufacturing and commerce. The
occupational exposure limits are of great value in protecting worker health and
safety, but their use and interpretation requires a thorough understanding of the
data upon which they are based, and of the process and rationale followed in their
development.
Basis for occupational exposure limits
The great majority of occupational exposure limits are set, appropriately, on the
basis of a biological effect using the rationale outlined above, without regard for
economic or other factors. There are a few occupational exposure limits for which
this cannot be said, however, and their interpretation again requires some under-
standing of the procedure by which they were set.
Biological effects
The documents supporting each standard will generally indicate the biological
response or responses which the standard aims to prevent or minimize. As time
passes and data accumulate, the specific biological effect addressed by the stan-
dard may change. In some cases a second standard has been added for a given
compound to control a newly discovered chronic response where the original
standard dealt only with an acute reaction.
Analytical factors
A final factor which must be considered in standard-setting is the current state
of analytical sensitivity for the agent in question. The practicing industrial hygie-
nist must have access to sampling and analytical techniques able to detect the
agent at and below the proposed standard. In a small number of cases this factor
has taken a predominant role. The most important example is the standard for
asbestos fibres in air, which was recently revised downward and set at the lowest
level detectable by readily available techniques. It was again acknowledged that
this standard probably will not provide adequate protection against cancer in
exposed workers, but the alternative was to set the standard at a lower level for
which only very expensive analytical procedures can be used.
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ACGIH
The American Conference of Governmental Industrial Hygienists (ACGIH) is
a private group organized in the late 1930's, consisting of industrial hygienists
and other occupational health professionals employed by a wide variety of
government agencies. Despite its name the ACGIH has no statutory authority
– its occupational exposure limits are only recommended guidelines for good
practice and are not directly enforceable by law.
Characteristics of TLV committee
The threshold limit values (TLV) are set by a committee of the ACGIH. The
committee consists of members of the conference, aided by unpaid consultants
who generally are employees of industry. The committee meets several times each
year to review each of its TLV, and publishes a revised list annually. As a result of
this continuing review, new data on a compound can be incorporated rapidly into
the rationale for the TLV, and its value can be adjusted if necessary to reflect the
new information. Thus the TLV are widely regarded as current, reflecting the
most recent data available. Since the TLV committee may act rapidly, without the
bureaucratic encumbrances of a government agency, it has been able to establish
TLV for over 700 substances, and to revise a large proportion of them at least
once, in its more than 50 years of existence.
TLV preface
The intent of the TLV committee in developing the guidelines is described in the
preface to the TLV booklet (3). The reader is strongly advised to read the preface
carefully, and to refer to it often in practice, when TLV or other guidelines are
applied.
Threshold Limit Values (TLV) refer to airborne concentrations of substances and
represent conditions under which it is believed that nearly all workers may be
repeatedly exposed day after day without adverse health effects. Because of wide
variation in individual susceptibility, however, a small percentage of workers may
experience discomfort from some substances at concentrations at or below the threshold
limit; a smaller percentage may be affected more seriously by aggravation of a pre-
existing condition or by development of an occupational illness. Smoking of tobacco is
harmful for several reasons. Smoking may act to enhance the biological effects of
chemicals encountered in the workplace and may reduce the body's defense mechanisms
against toxic substances.
Individuals may also be hypersusceptible or otherwise unusually responsive to some
industrial chemicals because of genetic factors, age, personal habits (e.g., smoking,
alcohol, or other drugs), medication, or previous exposures. Such workers may not be
adequately protected from adverse health effects from certain chemicals at
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concentrations at or below the threshold limits. An occupational physician should
evaluate the extent to which such workers require additional protection.
These limits are intended for use in the practice of industrial hygiene as guidelines
or recommendations in the control of potential workplace health hazards and for no
other use, e.g., in the evaluation or control of community air pollution nuisances; in
estimating the toxic potential of continuous, uninterrupted exposures or other extended
work periods; as proof or disproof of existing disease or physical condition; or adoption
or use by countries whose working conditions or cultures differ from those in the United
States of America and where substances and processes differ. These limits are not fine
lines between safe and dangerous concentrations nor are they a relative index of
toxicity. They should not be used by anyone untrained in the discipline of industrial
hygiene.
The TLV, as issued by ACGIH, are recommendations and should be used as
guidelines for good practices. In spite of the fact that serious adverse health effects are
not believed likely as a result of exposure to the threshold limit concentrations, the best
practice is to maintain concentrations of all atmospheric contaminants as low as is
practical.
--------------------ACGIH TLV/BEI Booklet, 1998 (3)------------------------------------------
Documentation
The booklet containing the TLV tables gives only brief information regarding the
basis for the TLV, in terms of biological effect addressed and supporting data.
These are contained in a much larger ACGIH publication, the “Documentation
of the threshold limit values and biological exposure indices”. This contains a
summary of the data and rationale for each TLV, with citations from the scientific
literature used in developing the adopted value. It is a very important reference to
which users of TLV should look for much useful information in interpreting the
values. The documentation is revised annually.
Present controversies
A criticism of the TLV committee has been raised repeatedly over the years. The
problem stems primarily from the misuse of the TLV by other organizations.
Despite the committee's disclaimer in the preface that the TLV are not absolute
boundaries between safe and unsafe conditions, and should not be given legal
status, they have been adopted in part by many states as legally enforceable
occupational exposure limits. As with many other occupational exposure limits,
these have been interpreted by many employers as the sharp boundaries between
legal and illegal, implying safe and unsafe. Hence, while the TLV committee has
made some effort to establish the philosophy that its guidelines are meant to
represent good industrial hygiene practice, (meaning that the employer should
take every effort to keep contaminant levels as low as possible, but always below
the TLV), their adoption by government agencies has caused their misinterpreta-
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tion, and a misunderstanding of good practice. The chief complaint lodged against
the committee, and perhaps the entire Conference, is the perceived lack of energy
in making its views known, both to industrial hygienists and to regulatory
agencies.
Application of threshold limit values
TWA
Unless otherwise noted the TLV is to be applied as a time weighted average
(TWA). This means that the average concentration over the 8 hour work shift
should be below the value given in the table; fluctuations above the TLV are
permitted, within limits, as long as there are sufficient fluctuations below the TLV
to keep the average below the limit. The mathematical expression for the TWA
calculation is:
TWA Concentration =  ∑ Ci x ∆ti / ∑ ∆ti
where Ci is the average concentration over time period ∆ti
∆ti is a period of time during which one sample is taken.
A series of such samples is taken to cover the entire period, so that the denomi-
nator in the expression equals 8 hours.
Excursions
Although fluctuations about the average are allowed for most materials in the
TLV list, it is recognized that there should be limits to these brief peaks as well.
Two approaches have been taken in attempting accomplish this. Where data exist
describing the human responses to brief exposure to the agent in question, a short
term exposure limit (STEL) accompanies the TWA value in the table. Thus for
carbon dioxide, for example, there is a TWA value and a higher STEL. STEL are
meant to apply to a fifteen minute period of exposure, meaning a time-weighted
average over that time. These TLV are meant to be applied in addition to the 8
hour TWA. Where no data are available with which to set a STEL, an excursion
factor limit of 3 has been used: the thirty minute peak is thus to be limited to three
times the 8 hour TWA as a general rule of thumb.
Ceiling
Substances known to produce adverse effects very rapidly, say within minutes
of the onset of exposure have been given special treatment by the ACGIH. Their
TLV are specified as ceiling values, indicated in the table with a capital C before
the value. This TLV is an airborne concentration never to be exceeded, using the
best available methods for sampling and analysis. Again, fluctuations in concent-
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rations are permitted, but the largest fluctuation must not exceed the ceiling value.
Thus no averaging is done for these substances, but very careful measurements,
using high quality instruments, are required.
Mixtures
Exposures to mixtures of two or more compounds in air pose serious difficulties
for interpretation of guidelines and occupational exposure limits. No general
approach has been agreed upon to account for possible interactions among
components of a mixture, but the ACGIH has offered a recommended approach.
When no information is available regarding interaction, two compounds present
together should be assumed to produce additive effects if their biological reactions
are similar. Thus, two compounds producing irritation at similar sites within the
respiratory system may be assumed to act additively: the response to the mixture
is the sum of the responses calculated if the compounds were present singly
at the same concentration. If the two compounds produce different biological
responses – one is an anesthetic and the other is a carcinogen – then in the absence
of information regarding interactions, the compounds should be assumed to act
independently: each compound is evaluated as if the other were not present.
Numerical examples of the calculations which apply to these two situations are
given in Table 1.
Carcinogens
The ACGIH committee treats cancer-causing agents in two ways, depending on
the extent of available data. When exposure data are sufficient, a TLV has been
assigned; In addition, a notation system has been developed which is intended to
show the nature and strength of the evidence that a substance is carcinogenic. The
categories presently in use are: A1, Confirmed human carcinogen; A2, Suspected
human carcinogen based on data in animals and insufficient data in humans; A3,
confirmed animal carcinogen with unknown relevance to humans for substances
where available epidemiologic evidence does not confirm an increased risk of
cancer in exposed humans; A4, Not classifiable as a human carcinogen based on
inadequate data; and A5, Not suspected as a human carcinogen since available
data are adequate and negative.
Non-standard work schedules
The TWA guidelines apply explicitly to a work schedule of 8 hour shifts, with 16
hours between each shift at an assumed concentration of the agent of near zero,
for five days with a two day weekend before the cycle begins again. Deviations
from this standard work schedule are becoming more common, but correcting the
TWA values to account for this is difficult, and ACGIH has made no recommen-
dation. It is probably not sufficient to adjust only for the increase in exposure
which occurs if the shift is, say, 10 hours long instead of 8; one should also adjust
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Table 1. Application of the threshold limit values when two or more contaminants
are present (Source: ACGIH TLV/BEI Booklet 1998:81-83 (3)).
A. Additive effects: Instead of comparing the concentration of each component to its TLV
separately, the following additive criterion is used:
Calculate  ∑ Ci/Ti  where Ci is the concentration observed for compound i
Ti is the TLV for compound i
If the result is greater than 1.0, then the equivalent TLV of the mixture has been exceeded.
Example: Air contains 250 ppm of acetone (TLV = 500 ppm), 150 ppm of sec-butyl acetate
(TLV = 200 ppm) and 100 ppm of methyl ethyl ketone (TLV = 200 ppm). All have mild
pulmonary irritant and anesthetic effects. The criterion is:
∑ Ci/Ti  = 250/500 + 150/200 + 100/200 = 0.50 + 0.75 + 0.50 = 1.75
The equivalent TLV of the mixture has been exceeded.
B. Independent effects: Compare each component to its respective TLV separately. If any
component is present in excess of its TLV, then the guideline is exceeded.
Example: Air contains 0.045 mg/m3 of lead (TLV = 0.05) and 0.7 mg/m3 of sulphuric acid (TLV =
1). One is neurotoxic and hematotoxic, the other is a potent respiratory irritant. The criteria are:
C1/T1  =  0.045/0.05  =  0.9 C2/T2  =  0.7/1.0  =  0.7
Neither TLV has been exceeded.
for the shortened recovery period between the longer shifts, but no simple method
for doing this has been proposed.
TLV for particulate matter
For chemical substances present in inhaled air as suspensions of solid particles
or droplets, the potential hazard depends on particle size as well as mass con-
centration because of: 1) effects of particle size on the deposition efficiency and
site within the respiratory tract, and 2) the tendency for many occupational
diseases to be associated with material deposited in particular regions of the
respiratory tract. 
The Chemical Substances TLV Committee has recommended particle size-
selective TLV for crystalline silica for many years in recognition of the well-
established association between silicosis and respirable mass concentrations. The
committee is now re-examining other chemical substances encountered in
particulate form in occupational environments with the objective of defining:
1) the size fraction most closely associated for each substance with the health
effect of concern, and 2) the mass concentration within that size fraction which
should represent the TLV.
The particle size-selective TLV (PSS-TLV) are expressed in three forms:
1. Inhalable particulate mass TLV (IPM-TLV) for those materials that are
hazardous when deposited anywhere in the respiratory tract. The inhalable frac-
tion is that portion of airborne particles entering the nose and/or mouth during
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breathing. This fraction is often less than unity owing to settling of airborne
particles due to gravity, and to effects of local air movement which may prevent
particles from being inhaled. The quantitative definition of IPM is shown in
Figure 1, as a graph of particle aerodynamic diameter versus the fraction of
particles, by mass, that are inhalable at each diameter. This criterion is based on
a series of investigations of particle collection by human head models in wind
tunnels under conditions designed to provide realistic representations of human
exposure. It should be noted that for particle aerodynamic diameters above 100
µm, too few data are available; the inhalable mass fraction is unknown, but does
not vanish at these diameters.
2. Thoracic particulate mass TLV (TPM-TLV) for those materials that are hazar-
dous when deposited anywhere within the lung airways and the gas-exchange
region. This fraction represents those particles which escape capture by the
surfaces in the head airways region – the nose, mouth and throat – and enter the
trachea during inhalation. Figure 1 indicates the dependence of this fraction on
aerodynamic diameter, and indicates that at 10 µm the thoracic fraction is 50%.
This criterion is based on experimental measurement of deposition in the head
airways conducted in human volunteers given controlled exposure to aerosols, and
it is in close agreement with the PM(10) criterion now used by the United States
Environmental Protection Agency in regulating outdoor concentrations of
particulate matter.
3. Respirable particulate mass TLV (RPM-TLV) for those materials that are
hazardous when deposited in the gas-exchange region. The latter is defined as the
portions of the lungs containing alveoli where oxygen and carbon dioxide are
exchanged between air and circulating blood. Anatomically, this includes all
surfaces distal to (downstream during inhalation) the terminal bronchioles, the
smallest airways which do not incorporate alveoli. Figure 1 indicates the respi-
rable fraction as a function of aerodynamic diameter. This criterion is also based
on experimental measurements of particle deposition within the conducting
airways during inhalation in human volunteers, and it indicates the fraction of
airborne particles which escape collection in the head or conducting airways, and
therefore are able to penetrate to the deepest portions of the lungs. It should be
noted here that the RPM measurement does not necessarily reflect deposition of
these particles in the gas-exchange region: some of the respirable particles which
penetrate to this level during inspiration do not deposit and are carried out with the
next exhalation. The measurement of the respirable particulate mass concentration
therefore represents the maximum potential exposure of the gas exchange region,
if complete deposition were to occur.
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Figure 1. ACGIH particle size selective criteria
The most significant difference from previous definitions is the increase in the
median cut point for a respirable particulate matter sampler from 3.5 µm to 4.0
µm; this is in accord with the International Organisation for Standardization/
European Committee for Standardization (ISO/CEN) protocol.
Application of the new criteria
Airborne particle standards such as the TLV are now being revised to incorporate
these criteria, when data are available associating health risk with the appropriate
measure of exposure. There are two general approaches to the measurement
of the concentration of particles within one or more of these size fractions. The
first method is to determine the particle size distribution in the sample from the
workplace by a suitable technique such as a cascade impactor or some equivalent
aerodynamic particle sizing instrument. Then, the appropriate particle size
selection criterion is applied to the data. This is illustrated in Figure 2. The figure
shows a hypothetical particle size distribution determined for example by a
cascade impactor, plotted as the mass concentration per unit size interval versus
the aerodynamic diameter. These data represent the distribution of mass concen-
tration in the ambient air, before inhalation. To determine the inhalable particle
mass concentration, the criterion must be applied as shown in Figure 2: the mass
concentration in each size interval must be multiplied by the inhalable mass
fraction corresponding to that size interval, and the resulting products are summed
to yield the inhalable mass concentration. Note that for size intervals less that 1
µm in aerodynamic diameter, nearly 100% is inhalable, while for size intervals of
30 µm or greater in aerodynamic diameter, the inhalable portion is approximately
50%. A similar method would be followed to determine the thoracic or respirable
mass concentrations, each requiring determination of the airborne size distribution
followed by application of the appropriate criterion.
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Figure 2. Application of size criterion
The second method is to use a particle sampling device whose collection
efficiency matches that of the size selection desired. That is, if one wishes to
determine the respirable particle mass concentration then a sampler designed to
collect particles with the same efficiency as the criterion should be employed. A
number of devices are available to accomplish this. One example is the combi-
nation of a cyclone placed upstream of a particle filter, and devices such as the 10-
mm nylon cyclone have been available commercially for many years. Analyses of
available data indicate that the recommended flow rate of 1.7 litres per minute
allows the 10-mm nylon cyclone coupled with a filter collector to approximate the
particulate matter concentration which would be measured by an ideal respirable
particulate mass sampler as defined above. A number of TLV have now been
developed which specify an airborne particle concentration as the respirable mass
fraction. These include TLV for crystalline silica and for elemental cadmium and
its compounds.
In contrast, devices for direct measurement of the inhalable and thoracic frac-
tions of airborne particulate matter have only recently been introduced, and their
performance has not yet been completely validated. For inhalable particulate mass
concentration measurements, a device developed by the Institute of Occupational
Medicine in Edinburgh, Scotland, has been recommended. Generally referred to
as the IOM sampler, this device is designed to collect particles with an efficiency
that matches that of the human respiratory system. With the emergence of this
method for determining inhalable particle mass concentrations, new TLV may be
se and existing TLV may be revised based on this fraction.
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Comparison of new and older particle sampling methods
One problem with this development is the need to determine the relationship
between particle mass concentrations determined by the older filter method and
the newer inhalable method. The older method has been thought for many years
to collect all particles with nearly 100% efficiency regardless of aerodynamic
diameter. This traditional “total” particle sampler would be expected to result in
particle mass concentrations higher than or equal to those produced by the inhal-
able particle sampler when both were employed in the same environment. A series
of experiments has now been conducted in a wide variety of work places where
airborne particles of different composition and size distribution were found. In
each setting, simultaneous samples were taken using the traditional “total” filter
method, and the newer IOM sampler designed to collect the inhalable particle
fraction. The two results were compared by calculating the ratio, S, of the
inhalable to the “total” particle mass concentrations.
S = 
If both sampling devices operated as anticipated, the value of S should be equal
to or less than unity. In nearly all cases, however, the observed value of S was
greater than unity, and ranged as high as 3.2 in some work places. Table 2
presents a summary of recent studies comparing the two sampling methods. This
seemingly contradictory finding has now been determined to arise from the
incomplete collection efficiency of the “total” particle sampling method. Filter
cassettes as used by most industrial hygienists do not in fact perform with 100%
collection efficiency at all particle diameters. Their efficiency is in general less
than that of the IOM sampler, especially when a substantial fraction of the
particles being sampled are at diameters above 10 µm. On the other hand, when
most of the particle mass is in particles with diameters of 2 µm or less there is
close agreement between the two methods. The data for samples from a welding
shop in Table 2 reflect this consideration.
A major consequence of this set of observations is that measurements taken
with the IOM sampler, or other device shown to conform to the IPM criterion,
should not be compared to a TLV which has been specified as “total” particle
mass concentration. From the data shown in Table 2, such a comparison could
lead to a judgement of overexposure which may be incorrect. The TLV committee
is now reviewing this problem and expects to provide advice on the matter soon. It
does not appear likely that the existing particulate matter TLV specified as “total”
mass concentrations will be adjusted to match the newer inhalable criterion, since
the adjustment is dependent on the particle size distribution present in the specific
work place being evaluated. New particulate matter TLV, however, will be
specified as one or more of the three size-selective fractions, whenever data are
available to support doing so. This newer specification will also be applied to
Mass concentration by IOM sampler
Mass concentration by “total” sampler
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Table 2. Summary of recent studies comparing “total” and inhalable particle concentra-
tion measurements. Adapted from Werner et al. (12).
Industry "Total" Sampler Inhalable
sampler
Component
sampled
Ratio S
Borates/ Boric acid 37 mm closed face IOM Total aerosol 2.20
Nickel mine 37 mm closed face IOM Nickel 3.20
Nickel mill IOM Nickel 2.72
Nickel smelter A IOM Nickel 1.65
Nickel smelter B IOM Nickel 2.84
Nickel refinery IOM Nickel 2.12
Nickel alloy 37 mm closed face IOM Nickel 2.29
Nickel plating A 37 mm closed face IOM Nickel 2.02
Nickel plating B IOM Nickel 3.01
Lead smelter 37 mm closed face IOM Lead 1.77
Cadmium 1.76
Machine shop 37 mm closed face IOM Cutting oil 2.96
Woodworking Closed face, 4 mm opening IOM Wood dust 1.79
Total aerosol 0.95Welding repair shop
Aluminium 1.36
Woodworking Closed face, 5.5 mm opening IOM Wood dust 1.79
some existing particulate matter TLV, again where size-selective measurements
are available.
Thoracic particulate fraction
As for the thoracic particulate mass criterion, one device has been introduced
within the past two years which is claimed to conform. This device incorporates a
cascade of virtual impactors coupled with filters for collection, and is designed to
separate airborne particles into three fractions: the first stage contains the respi-
rable fraction; the sum of particles found on stages one and two represents the
thoracic fraction; the sum of particles found on all three stages represents the
inhalable fraction. Validation data are now being collected with this new sampler,
and should be available soon. At this point there are no particulate matter TLV
containing the thoracic particulate mass specification since few measurements
have been made which have been demonstrated to meet the criterion. As new
devices are introduced, it is anticipated that data will accumulate and it will soon
become possible to develop thoracic particulate matter TLV.
Biological exposure indices
Biological monitoring is generally described as the planned and repeated collec-
tion of specimens of tissue or body fluid, for the purpose of estimating the
chemical composition of the body's internal environment. The repeated aspect
differentiates monitoring from sampling, and emphasizes the point that temporal
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changes in chemical composition are just as important as the estimates at a single
time.
Occupational biological monitoring must be viewed as complementary to, and
not a replacement for, the more traditional measurement of airborne concentra-
tions of chemical agents. It provides additional information which can be of great
value in evaluating and controlling risky exposures. This form of exposure
monitoring invokes some additional requirements, however, one of which is the
existence of reference values against which observed biological concentrations
may be compared in order to form judgements about the acceptability of the work
place conditions.
One substantial collection of reference values for biological monitoring in
work places is the list of biological exposure indices published by the ACGIH.
Organizations such as this, together with governmental regulating agencies,
perform a key role at the interface between science and policy: ideally, their
mission is to use the best available scientific and technical data to set recom-
mended or regulatory limits that will minimize the health risks to workers while
maximizing the benefit to society of the economic activity associated with the
work.
The defining characteristics of the BEI
The BEI are reference values intended as guidelines for the evaluation of potential
health hazards in the practice of industrial hygiene. Thus, when BEI are used by
physicians, nurses, engineers or industrial hygienists, their principal application
should be to support prevention of injurious exposures.
The BEI are developed by the BEI committee of the ACGIH, which consists of
volunteer scientists and practicing professionals with expertise in occupational
medicine, toxicology, industrial hygiene, analytical chemistry, biostatistics and
epidemiology. The present committee members include specialists from the
USA, Japan, Germany, Switzerland, Taiwan and the United Kingdom, employed
in academia, government or private industry (the last category of members does
not have voting privilege, but otherwise participates fully in the process.) The
committee meets twice per year to develop new reference values and to conduct a
regular review of existing BEI as new data emerge. Several values have under-
gone significant revision as a result of such review. Examples will be described
below.
The BEI are intended for use in biological monitoring where the goal is the
determination of the worker's internal dose, or biologically effective dose, of a
chemical. The determinant may be the parent compound itself, metabolite(s), or a
characteristic reversible biochemical change induced upon absorption. The index
values represent the level of the determinant most likely to be observed in speci-
mens collected from a worker with an internal dose equivalent to that arising
solely from inhalation exposure at the TLV concentration. Thus most of the BEI
are closely linked to the corresponding TLV, and are based on preventing the
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same health effect addressed by the TLV. This does not imply, however, that
airborne concentrations and biological levels must always be correlated in expo-
sed workers, since routes of absorption in addition to inhalation are possible.
Where this occurs, comparison of biological levels to the BEI takes on special
importance, since the BEI represents the acceptable internal exposure regardless
of the route(s) of entry.
Present status - procedure for establishing a BEI
Establishing a BEI has evolved since the early days of the BEI committee into a
staged process consisting of a) feasibility analysis, b) development of a proposed
BEI, c) formal publication of that proposal with an invitation for comment from
all parties, d) review and possible revision of the proposal, and e) final adoption
by the voting members of ACGIH. At each stage, the actions of the committee
are subject to review by the ACGIH Board of Directors, elected in turn by the
membership. One of the critical decisions in the process is the initial one, as to the
feasibility of establishing a new BEI. In the course of making this decision the
committee considers several criteria which are discussed in a written feasibility
assessment prepared by one or two committee members. The criteria are:
Extent of systemic absorption and disposition
Substances must be absorbed into the circulation to the extent that target tissues
remote from the site of entry are affected, and so that accessible biological fluids
or tissues will contain the chemical or its metabolite in detectable concentration.
An industrial chemical with potent toxic properties which exerts its effect only
topically or only at the site of absorption is not a candidate for setting a BEI since
biological monitoring is unlikely to generate information useful for preventing or
minimizing exposure.
Size of the exposed worker population
Although there is no specific quantitative requirement for this aspect, data on the
size of the population are needed. In general, exposures to workers should occur
in more than a single industrial facility, and preferably in the work places of more
than one company. Equally important is the recent trend in these data, as a sub-
stance whose use in industry is decreasing may be of much less interest than one
whose production and use are growing. The influence of this factor may be dimi-
nished for a substance with very potent toxicity for which other feasibility criteria
are particularly compelling, such as the glycol ethers which may penetrate the skin
in significant amounts.
Existence of a TLV for the substance
The great majority of BEI are directly related to the corresponding TLV. They
address the same health outcome and represent the expected internal dose
corresponding to inhalation at the TLV. Exceptions to this criterion have been
made in the past, and they establish a precedent for similar future exceptions
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where the other feasibility criteria argue strongly for establishing a BEI. The
present exceptions are BEI for classes of compounds inducing methemoglobin-
emia, and for those inhibiting acetyl cholinesterase.
Toxicokinetic data in humans are available
There should be sufficient data of high quality, which describe the absorption,
systemic distribution, metabolism, storage, and excretion of the compound or
its metabolites. These are necessary to support the selection of the appropriate
analyte, the tissue or fluid to be sampled, and the timing of the sample. The
committee requires that the toxicokinetic studies be published in the peer-
reviewed scientific literature, so that their quality can be assessed by all interested
parties. In some instances validated toxicokinetic models have been used where
experimental human data were not sufficient. Further, toxicodynamic data may
also be appropriate in instances where the anticipated BEI would be directly
related to health effect rather than to an airborne concentration. This particular
means of developing a BEI has been used only rarely to date.
Analytical chemical methods are available
Data in the peer-reviewed literature must demonstrate that a method exists for
assay of the determinant with acceptable accuracy, precision, and sensitivity.
These performance characteristics must permit analysis of the determinant in the
recommended tissue or fluid sampled, at levels both below and above the antici-
pated level of the BEI. Inadequate analytical methodology will preclude the
development of a reference value.
An affirmative feasibility decision launches the development of a proposed BEI
by one or two members of the committee. The written proposal will include the
identity of the industrial chemical or category of substances addressed, together
with its CAS number and chemical formula. The recommended BEI includes
the identity of all determinants – parent compound, metabolite(s), biochemical
change – together with the medium to be sampled, the time of collection relative
to the exposure period, and the numerical value of the index expressed as a
concentration or percentage of normal. In many instances there will also be a
notation which marks one or more special considerations for the BEI, such as the
need to account for background levels in workers due to exposure outside the
work place.
The proposed BEI is supported by a document which reviews the scientific data
used in developing the reference value, and which contains a synoptic rationale
for the recommendation. The documentation must conform to a standard format
incorporating relevant physical and chemical properties of the chemical, toxico-
kinetic data, discussion of possible non-occupational exposure, the value and
rationale for the corresponding TLV, a discussion of sampling and analytical
methods for the determinant(s), anticipated biological levels without occupational
exposure, the timing of appearance of the determinant, factors affecting inter-
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pretation of the measurement, the justification for the recommended BEI together
with a critical assessment of the current data available, and finally a description of
reference values recommended or required by other organizations. All literature
used in the preparation of the documentation is cited, and a copy of each item
must be provided for archiving.
The BEI committee then conducts a thorough review of the proposed BEI and
its documentation. A member not involved in the preparation of the proposal
is assigned to lead this review, during which special attention is paid to the
correspondence of the BEI to the TLV if that approach has been used, or to the
relationship to health effects data if not. Conformance to the feasibility assessment
is considered, and the practical aspects of sampling, analysis, and interpretation
are examined. The review process is one of scientific judgement based upon the
weight of available evidence, and does not include a quantitative risk assessment.
The approach in most cases has been to select the level of each determinant which
is most likely to result from inhalation exposure at the TLV. The decision takes
account of typical workers' physical activity during exposure, and pays particular
heed to experimental or epidemiologic data on the toxicokinetics of the com-
pound. The final recommendation is invariably a consensus of the voting members
of the committee. Revisions to the documentation are often agreed upon at this
stage in response to comments from the committee members.
The proposed BEI must remain on the list of “Notice of intent to establish or
change” for at least one year, after which the committee reviews all comments
received as well as any new scientific date to emerge. Revisions may be made to
the BEI and its documentation, after which another consensus is reached regarding
adoption. If proposed BEI is revised at this point, the new proposal must spend
another year on the Notice of Intent. After the required notice period, a recom-
mendation for adoption is again reviewed by the Board of Directors and the
ACGIH membership. Final adoption results in publication of the BEI in the
booklet as an established reference value, and the incorporation of the new
documentation into the three-volume set published by the ACGIH, containing
all the documentation for the TLV and BEI.
A significant aspect of the TLV and BEI procedure is the periodic reexami-
nation of the adopted reference values. Generally the original authors of the
documentation are expected to monitor the scientific literature for new data which
may bear on the BEI. A proposal for revision may be presented at any time, and
can be acted on within one year of presentation. In this way the collection of BEI
can be kept consistent with current science, and thus will be of maximum utility to
occupational health practitioners. The annual publication of the TLV/BEI booklet
reveals numerous revisions as a consequence of this continued surveillance. The
frequent updating of the ACGIH reference values stands in marked contrast to the
much slower (legislatively mandated) process of the US Occupational Safety and
Health Administration in revising its regulations governing the same substances.
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Occupational exposure limits - an ethical
dilemma1
Tor Norseth, National Institute of Occupational Health, Oslo, Norway,
www.stami.no, e-mail: tor.norseth@stami.no
Introduction
Occupational exposure limits have been a feature of the industrialized world
for more than fifty years. The concept of exposure limits has been important for
the improvement of the working environment. The process of establishing
occupational exposure limits has, however, varied between countries, and the
concepts of such limits have been poorly described.
Control of risks from exposure to chemicals requires first of all a scientific
assessment of the potential effects at given exposure levels (risk assessment).
Based on the results of the risk assessment, and taking into consideration other
factors, a decision making process aimed at eliminating or reducing the risk under
consideration, can be started (risk management). This internationally accepted risk
assessment paradigm includes the four steps: Hazard identification, dose-response
assessment, exposure assessment and risk characterization. This framework
provides a basis for a structured review of information relevant to estimating
health outcomes of exposure to chemicals. The paradigm differentiates between
the scientific approach of risk assessment, and the human value-loaded approach
of risk management taking into consideration also technological, economical,
socio-political and other cultural considerations.
It is important that both the biomedical and toxicological scientific criteria, and
the feasibility criteria (socio-political, economical, technological and cultural) are
made visible in the procedure of setting occupational exposure limits. Feasibility
and socio-political considerations are, and have always been, important in this
process, but these processes have not always been visible. These considerations
are based on value judgements, but they are not always clearly separated from the
scientific process.
Human value judgements are, however, also present in the apparent scientific
risk assessment process, though most often hidden and thus visible neither to
experts nor to the public. Thus, the public and even some biomedical experts are
led to believe that it is possible to suggest pure scientifically based exposure
limits, which subsequently are used as a basis for the risk management process.
                                                 
1 This presentation is a revised copy of a presentation with the same title published in Arbete och
Hälsa 1993;15:123-135.
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This involvement of science in risk management by the participation of the
scientist by profession, in deciding numerical values for occupational exposure
limits is a violation of some of the most important normative values of science.
Both scientific objectivity and the closely related principles of disinterestedness
and unbiasedness are violated. On the other hand, no research is perfect from the
scientific normative point of view. Both models and results are always subject to
subjective analysis, but the scientific method usually minimizes this objectivity
problem. In addition, we are all biased – experts and lay people – by contextual
human values in the form of personal, social, cultural, or philosophical emphases
which typically influence the research processes. Contextual human values are
generally accepted in the risk management process, but such values may unaccept-
ably influence the results (the exposure limits) if they are believed to be part of
an objective scientific judgement. This is the case if scientists as such participate
in developing numerical values for acceptable risk. Even risk characterization
may be a dubious task for science in this process. Whether or not to classify a
substance as a carcinogen is not only a normative process. Clearly, value judge-
ments are part of the process.
Science in our culture in a way represents the truth, but the scientific truth in
a risk assessment/risk management paradigm is not necessarily the social truth.
The social truth – the occupational limit value – must be judged fair and just.
Contextual human values from stakeholders – and the scientist by profession is
not a stakeholder in this process - are important and necessary in the risk manage-
ment paradigm. This problem cannot, of course, be completely solved, but the
problem clearly indicates that the scientist – as a scientist – should not unduly and
invisibly influence the risk management process from the power position of
science. There is nothing like a pure health based limit value based on scientific
facts; all limit values are based on human value judgements. Thus, both the risk
assessment and the risk management paradigms include human value judgements
with moral content and ethical problems.
Toxicological background of the occupational exposure limits
I will in the following discuss some aspects of the four steps in the risk assessment
paradigm to explain my arguments above.
Hazard identification
Communicating risk to workers and to the public is a prerequisite for worker and
public participation in the procedure of setting exposure limits, and thus a neces-
sity for the ideal procedure as described previously. There always is, however, a
conflict between the principles of critical hypothesis testing and communicating
risk. Probably the requirements of establishing a scientific truth ideally require too
much time before risk communication and prevention should be initiated. On the
other hand, we live in a risk oriented society where the risk paradigm by itself
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may constitute a health hazard. This is an ethical problem with no scientific
answer, a problem that is handled by all of scientists, laypeople, based on our own
value judgements. The so-called precautionary principle – used and misused – is a
part of this problem. A further discussion of use and misuse, and of the scientific
and moral problems of this principle, is outside the scope of this presentation. I
will give an example from the Norwegian classical literature to illustrate the risk
communication problem.
In the play "An enemy of the people" by the Norwegian author Henrik Ibsen,
Dr. Stockman ended up as "an enemy of the people" when he informed the autho-
rities and the public about the bacterial contamination of the water used for the
flourishing health baths in the community. And he himself as expressed in the
play, expected official credit and public appreciation. His statement that the man
standing alone is also the strongest may bear some implication for the process of
improving the working environment by revealing information of conflicting
interests to the parties involved (workers and management). The authorities and
the public in this case also wanted Dr. Stockman to let the consequences influence
his scientific conclusions, but he did not and became "an enemy of the people".
There are too many examples where consequences have influenced scientific
conclusions. This is an important ethical problem with many aspects in to-days
human genome research. Should we refrain from doing some experiments because
of misuse possibilities of methods or results? And what constitutes a misuse?
Dose-effect and dose-response assessments
The interaction between a chemical and an organism can be described by two
different concepts, the dose-effect and the dose-response. The dose-effect denotes
the relationship between the dose and a graded effect, or different effects, in the
individual. The dose-response describes the relationship between the dose and the
frequency of a given effect in the population.
At the molecular level, the graded dose-effect may represent a dose-response
if receptors or binding sites are taken to represent individuals in a population.
Different effects thus represent other classes of binding sites or receptors. The
general requirements of a dose-effect relationship are that there is a reproducible
relationship between dose and effect, and that increasing doses generally lead to
an increased number of effects or more serious effects. In other words, there is a
reproducible relationship between the dose and the induced pathology (type-I-
toxicology).
It is convenient in the context of exposure limits and risk management in
general, to distinguish between the two different operational concepts of dose-
effect and dose-response, even if these are not universally accepted risk assess-
ment and risk management paradigms. These two concepts, however, also make it
easier to understand the philosophy and ethical dilemmas of exposure limits.
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Validity of the dose-effect, dose-response and threshold concepts – risk
characterization.
It is important to note that the operational concept of dose-effect as described
above is not equally valid for all kinds of effects. Mutagen and carcinogen effects
are the exceptions most often discussed, but there are also other effects involving
specific biological mechanisms that do not follow ordinary dose-effect principles.
These are foetal cellular differentiation or immunological processes (allergy or
immunotoxicological effects) where there are no reproducible correlations be-
tween dose and the induced pathology (type-II-toxicology). This has important
implications for the setting of occupational exposure limits for some chemicals.
For mutagen and carcinogen effects, even the lowest dose, because of specific
biological mechanisms (e.g. cell proliferation), may cause the most serious effect
(death). Neither the requirement of increasing doses causing more serious effects,
nor that small or limited doses may be without effects are present in such cases.
The generally accepted risk assessment paradigm denotes these effects as effects
with no threshold, a statement that I think is a serious misconception. All effects
have thresholds at the individual level. The dose-response represents the distri-
bution of the individual thresholds for a given effect for any effect in any
population. Even cancer, in case of the single hit carcinogenesis theory, is a
stochastic process. The distribution of cancer in a population exposed to one
molecule, which theoretically may cause cancer given the single hit theory,
represents the distribution of the thresholds between individuals for this effect,
as for all other types of effects.
The distribution of the thresholds is the dose-response curve, which, on the
other hand, has no threshold. The population threshold, or expressed differently,
the dose-response threshold, is nothing but a statistical power problem and as
such not a biological threshold. This is equally true for all kinds of effects. With
increasing doses, the probability of one hit may increase linearly, but in each point
of this linearly increase there is a probability distribution for cancer as a result
of the hit. Consequently, the differences between cancer and mutations and other
effects do not relate to thresholds, but to the simple fact that even the “lowest
dose” (one molecule) may cause the most serious effect (death) – the requirements
of dose-effect concept are not present.
Thus, even if genotoxicity, carcinogenicity and exposure in sensitised indivi-
duals should be treated differently from other effects, this cannot be substantiated
or explained by thresholds or no thresholds.
Dose-effect and dose-response in setting occupational health limits
No generally applicable function can be given for the dose-effect relationship for
different chemicals, but the dose-response function is, as mentioned, ideally de-
scribed by the normal distribution. Toxicologically, the occupational exposure
limit, when agreement has been reached on the effect that should be prevented, is
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the numerical dose value that represents the acceptable frequency of the chosen
effect in the exposed population.
The risk management process therefore involves two different value judge-
ments. The first is the selection of critical or adverse effect; and to define the
value loaded terms critical and/or adverse, the second is to choose the acceptable
probability of this effect to be found among exposed individuals. And the
scientist, as a scientist, should not participate in any of these value judgements.
The concepts of ethics and morality
In this part of my presentation I will go through some principles of ethics and
ethical argumentation that I feel are important for understanding the concept of
occupational exposure limits.
Health based occupational limits
The intention of the above short toxicological review has been to demonstrate
that the occupational exposure limits has never been, and can never be, a problem
of biomedical sciences alone. Feasibility including socio-political, cultural and
economical considerations, and therefore also the concepts of ethics and morality
are always involved in the process.
It is impossible to discuss the moral dilemmas of exposure limits without under-
standing both the concepts of toxicology and those of ethics and morality. The
claim that it is possible to develop purely health-based limits demonstrates that
such understanding is not generally acknowledged. A health based occupational
limit is a nonsense-term, which should not be used. The term signals, and some
people even seems to believe, that it is possible, if health related research only is
applied, to suggest a scientifically based numerical value for risk acceptance. Both
the risk concept and the health concept are, however, loaded with contextual
human values, and not even scientists live in a social and cultural vacuum. The
scientist may hopefully be able to estimate the probability of different effects at
different doses, and these estimates may be denoted as health based. Suggesting
an occupational limit, on the other hand, is always a political decision with a
number of ethical problems. The scientist must, of course, be allowed to partici-
pate in the process as an ordinary citizen. I would still recommend, however, that
the scientist be not invited to play both these roles in the practical limit setting
process. The separation between roles has been experienced to be difficult, and the
public may misinterpret the roles to believe the limits are scientifically based only.
The necessity of toxicological knowledge in setting occupational exposure limits
is generally accepted, but the theories of ethics and value judgements have been
neglected.
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Morality – a concept of right and wrong
Morality is usually regarded as the principles and values of a person or of a
group. Such principles and values determine the behaviour in specific situations.
Morality is thus a behaviour pattern based on certain assumption of right and
wrong. Important moral problems that always have been discussed throughout the
history of philosophy are how the concepts of right and wrong should be inter-
preted. Other problems are how to define moral virtue, or what is morally right or
wrong, and how to explain the morality or behaviour of a person or of a group.
Ethics – a methodological approach to morality
Ethical dilemma in the heading of this presentation indicates that there are
problems in applying the concepts of ethics in the discussion of the morality
of establishing occupational exposure limits. The implication of ethics as a
theoretical and systematic system for the description and treatment of moral
problems does not have a general support. Etymologically it is perhaps no reason
to separate the two concepts ethics and morality. Ethics is of Greek origin and
morality comes from Latin. Both have to do with conduct and behaviour. Being
accustomed to the reduction principles of models in the natural sciences it seems,
however, reasonable to regard ethics as the methodological approach to morality
- as research is the methodological approach to science. Given these methods and
the understanding how to use them - and only then - it is possible to discuss the
morality of the concept of occupational exposure limits, and to participate in the
discussion of specific numerical values without the subjective involvement of
interpersonal destructive moral rejection and denouncement.
Ethics as the methodological approach to morality is not to be regarded as a
subject for specialists alone. It is necessary to understand one's own interpretation
of the concepts of ethics and morality as well as the concepts of biology and
toxicology to take part in any process of establishing occupational exposure limits
- generally in any standard setting process. The rejection of these requirements
with a general denial of the involvement of human value judgements in all kinds
of standard setting is destructive in the process of establishing just exposure
limits.
I feel that it is important openly to discuss the moral aspects both of the concept
of exposure limits and that of setting the actual numerical value. The goal of such
discussions is not to put the fellow human beings on a scale of "bad" or "good"
dependent on individual attitudes, but to obtain an intellectually balanced and
reflected attitude to the many normative and human value loaded problems in
toxicology and in occupational health.
Normative or provisional- and descriptive ethical theory
The normative or provisional ethical theories suggest principles and appraisals for
morally correct and acceptable behaviour. Possible questions are: What should we
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do? Or: How should we behave? The biblical: Thou shalt love thy neighbour, as
the most important moral virtue is an example of normative ethics. The parallel to
occupational exposure limits should be: The working environment should never
cause health impairments.
Descriptive ethical theory refrains from providing what to do or not to do, but
limits the description to the principles and practice of morality. Questions like:
Are there generally acceptable important moral virtues among different cultures?
Or: What is the content of the concept of high moral virtue? Setting occupational
exposure limits the corresponding problem should be: How to evaluate accept-
ability in risk assessment?
Ethics may thus serve descriptive and analytical purposes only and is thus diffe-
rent from morality. Also normative ethics must have a descriptive and analytical
part to differentiate it from preaching, even if there is a close connection between
theological and philosophical ethics, and thus between religion and morality.
Teleological and deontological ethics
There is almost an indefinite number of ways to describe and characterize ethical
theories. It is outside the scope of this presentation and this course to give a
complete overview. For the purpose of this course it is, however, important to
discuss the differences between ethics based on the concept of moral value and
that based on the concept of duty.
If moral value is the basic concept it becomes important to define and describe
the concept of high moral value. Dependent on the chosen definition different
ethical theories like hedonism with pleasure as the ultimate goal, eudemonism with
a corresponding stress laid on happiness or satisfaction, or utilitarism, which
advocates utility as the ultimate moral virtue, have been suggested.
Value oriented ethical theories are often teleological or aimed towards a given
goal (gr. telos) for human behaviour. Important in these theories is therefore the
ways and means to reach these goals. Behaviour in a manner consistent with duty
is not a virtue by itself, but only a method to reach a given goal. The implications
for the principles of occupational exposure limits should be obvious: Some
workers must suffer to the benefit of the majority (the society as a whole).
Ethical theories based on moral duty (deontological ethics) have the opposite
approach to the relationship between moral virtue and duty. Behaviour in a
manner consistent with duty is a virtue, only if based on duty, and for that cause
alone. It seems that this duty cannot be rationally explained, but depends on the
consciousness within oneself, of the choice one ought to make between right and
wrong. The duty itself is the highest moral virtue without taking into consideration
results or consequences of the behaviour or duty determined action. From the
occupational exposure limit or occupational health point of view, there are good
reasons for hesitation if exploitation of ongoing developments in biotechnology
and molecular biology would be regarded as the duty of the scientist. On the other
72
hand, we may need a consciousness within ourselves to limit the utilitaristic
approach offered by a corresponding teleological model.
Moral virtue – scientific knowledge and the free will
A classical ethical problem, which obviously relates to occupational exposure
limits, is the relationship between moral virtue and scientific knowledge. Some
philosophers (Socrates and Plato) seem to have meant that knowledge in some
form was both necessary and sufficient for high moral virtue. Those who regard
volition and emotion as more important for behaviour oppose this rationalistic
and intellectual approach to morality, which indicates that morally unacceptable
behaviour is based on mistakes or lack of knowledge.
Closely related are the ethical problems of one's free will, how behaviour is
motivated and how to influence motivation. There is an ongoing discussion among
philosophers about the importance of such questions for the understanding of
ethics. Such questions are obviously important in the context of ethical problems
and occupational exposure limits and may relate, among other factors, to the
contextual bias previously mentioned.
It has been argued that it is theoretically impossible to logically deduct nor-
mative moral statements on valid and true premises. The consequence of this is
that moral values are always subjective and can neither be true nor false, neither
good nor bad, neither correct nor incorrect. Examples, which indicate that this is,
however, probably not true, are the so-called applied ethics, which seems to
unfold in medicine, in biomedical research and recently in biotechnology and
molecular biology. The decisions and statements seem to reflect a set of moral
virtues and principles based on generally accepted human value judgements.
Applied ethics also seems to gain momentum as an increasing number of
individuals or groups understand that all "reasonable" and "rational" human
activity; political, economical, cultural or scientific, and even the use and under-
standing of human language, necessarily presumes accepted norms and human
values. The interest in ethical and normative processes increases and promotes
discussion also among others than groups of professional philosophers.
The purpose of such discussion is not necessarily consensus on moral values.
Increased attention and mutual understanding based on a better communication to
others of the background of one's own moral values, of what seems to be right or
wrong, are important. According to ethical theories it is possible by such argument
to move towards an agreement that is not based on a utilitaristic principle, but
towards an agreement which represents the universally correct moral truth, the so
called reflective equilibrium (Rawls's theory). With mutual distrust and condem-
nation, this discussion is impossible. The universe in such cases should be defined
as those taking part, or being represented by the participants in the discussion.
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A question - and a possible model for moral reasoning
Finally, let us try to apply ethical theories for discussing a basic conceptual
problem of occupational exposure limits: Should we (the society) accept that
some workers are exposed to hazardous chemicals and possibly to a higher risk
than others?
Moral reasoning – or ethical analysis – may be based on the following four
important requirements:
1. Issues or points of conflict
2. Interested parties – stakeholders
3. Consequences
4. Obligations
I will not go into details on the description of all the requirements in this specific
case. The four points can be used as a framework for analysis of this and similar
problems. Each of us will probably answer the question by a combined deontolo-
gical and teleological ethical approach. We (the society) accept that some workers
are exposed to a higher health risk than others because of the consequences to the
economy and the development of our society not doing so. This is the teleological
model implying an utilitaristic approach based on cost-benefit. It must be noted
that this is not a scientific assessment. It is a value judgement based on conse-
quences.
A warning must be given at this stage. Decision makers in politics and admini-
stration may try to interpret obvious value judgements as scientific facts. This is
specifically important to be aware of by scientists involved in the risk assessment
procedure. It is important to remember that scientific truths or facts should always
be based on scientific conventions only, and never on the consequences of the
truths or facts. The fact that taking consequences into consideration often may
offer an easy way out of difficult ethical problems makes this important require-
ment of science even more important to remember. If scientific truths or laws are
changed according to consequences, important principles of the philosophy of
science are violated. Such behaviour may even in general threaten the scientific
foundations of our societies.
Most of us would, however, probably claim that there is a limit of the utilitarian
approach to the ethical dilemma in question suggested above. Based on our intui-
tion there is a limit, which cannot be exceeded whatever the consequences might
turn out to be. This is based on a deontological ethical model, which presupposes
values that cannot be discussed, values without rational explanation. These may of
course relate to one’s obligation as a scientist – or as a medical doctor. And who
are the stakeholders in a case like this. Why cannot the worker decide for himself?
It seems to me that discussions about exposure limits are often confused because
the structure of moral reasoning is not clear to everyone.
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I have previously discussed the concepts of scientific truths and legal truths.
Whether it is possible to define a moral truth in the context of the exposure limit
paradigm is very interesting. According to the ethical theories (Rawls's theory) it
is possible by continuous individual reflective reasoning and argumentation to
reach a morally correct solution to all problems as a limit function. I am not in the
position to discuss this postulate in depth, but I feel that the theory is applicable
to solve ethical problems in the process of setting exposure limits. To reach an
answer to the questions on acceptable risk we should all start out with our own set
of values trying to reach this rational reflective equilibrium by open-minded
exchanging and interpreting our own values and knowledge with others. This
process presupposes awareness of the ethical model used for us, mutual respect
for individual values, and organizational structures for discussion. The goal is not
necessarily consensus or persuasion, but rather conviction in the group that the
decision reached is morally fair and just. Taken universally this would constitute
the moral and juridical truth, but not necessarily the scientific fact.
Summary
The exposure limit paradigm differentiates between the scientific approach of risk
assessment and the value judgements of risk management. It is important that the
concepts of both risk assessment and of risk management are visible.
Experts involved in the risk assessment process are familiar with toxicology,
but often unfamiliar with ethics as a methodological approach to moral problems
inherent also in science. Utilitarism seems to be the most common approach to the
ethical dilemmas of the occupational limits paradigm, but deontological principles
applied in professional ethics seem to function as a limitation of the utilitaristic
principle in practice.
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Dermal exposure
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In several occupations and work situations skin exposure to chemicals is frequent.
It may be deliberate or unintentional, recognized or unknown in any combination.
It may occur as direct handling of contaminated goods or objects or indirect by
touching contaminated surfaces or coming from diffusion through working clothes
and protective gloves. Examples are handling manufactured goods soiled with
cutting fluid, cleaning the hands with organic solvents after they are heavily soiled
or spreading of toxic, allergenic or carcinogenic compounds to the skin in so small
amounts that it is not noticeable. If this exposure will represent a health hazard to
the exposed person will depend on the amount of chemical, length and intensity of
exposure, and type of chemical or product the skin is exposed to.
The skin is the largest single organ of the body with a weight of about 4 kg
and a surface area of about 1.8 m2 on a man of approximately 90 kg. The skin
consists of three distinct layers, the epidermis, the dermis and the subcutis. The
physiologically most important properties are located in the outermost layer of the
epidermis, stratum corneum, consisting of flattened enucleated keratinocytes with
a structured intercellular lipid domain surrounding them. The skin is a barrier to
our environment with properties to enclose and regulate the body homoeostasis
regarding water and temperature. It also is a barrier against invasion of micro-
organisms and physical injury. The skin is additionally involved in our behaviour
functioning as a signalling system (10). The barrier properties of the skin does
not only regulate water loss through diffusion but is in addition a barrier against
absorption of chemicals in our environment. The skin is constantly exposed to our
environment and all types of dermal exposures present there which makes it
vulnerable to injury.
Dermal exposure to chemicals can lead to systemic and/or local reactions
depending on the type of exposure. Dermal exposure is usually hard to determine
and quantify and there are several methods to assess and visualize skin exposure.
These methods include the use of fluorescent compounds, personal samplers,
coveralls, tape stripping, and washing of exposed body parts (2, 3, 4, 10, 12). The
methods can give qualitative or quantitative results depending on the situation and
technique used.
Recently an attempt to make a structured view of dermal exposure has been
published (11). This model takes into account the direct distribution of cont-
aminant from the source to the skin and clothing. It also deals with several ways
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of redistribution from clothing and contaminated skin to other surfaces that may
become contaminate and act as secondary sources of contamination. This
schematic view is a big step towards a better understanding, quantification and
prediction of dermal exposure but needs further development to be the powerful
tool it is expected to become.
The dermal exposure to chemicals can lead to various reactions systemically or
locally in the skin. The primary step in this is the absorption of the chemical into
the skin. The major route of absorption of chemicals through the skin is through
the epidermis. In addition to that the skin appendages, hair shafts and sweat ducts,
may contribute in a minor way. Skin absorption is influenced by a number of
factors of which the physico-chemical properties of the penetrating chemical, the
vehicle and the concentration of the chemical in the vehicle are important. The
status of the skin, the area and location of exposure and whether the exposure is
covered or not are other important and rate regulating factors. Skin absorption is a
passive diffusion and follows Fick’s law of diffusion (1). The theory of absorption
is discussed further in the chapter “Dermal absorption and principles for skin
notation”, by Johanson G.
The result of dermal exposure, as was mentioned above, varies. The absorption
of chemicals through the unprotected skin adds to the total body burden emanating
from other routes of absorption. The systemic effect following skin absorption
varies depending on the chemical and dose absorbed. It can either be a direct
intoxication following absorption of high amounts of toxic chemicals such as
pesticides, certain organic solvents and other systemically toxic chemicals. It may
result in the induction of cancer following long term exposure to carcinogenic
chemicals in low doses. Other direct target organ effects may also follow on
systemic absorption at dermal exposure. Systemic intoxication is always at risk
following dermal exposure to toxic chemicals but the lethal dermal dose is for
most chemicals higher than the oral but several chemicals have a pronounced
toxicity at skin exposure with doses equal to the oral dose.
However, the most commonly seen effects following dermal exposure are
localized to the skin. Several chemicals are lipophilic and act as delipidizers,
extracting the skin lipids and thus influencing the integrity of the skin barrier.
Once or twice can easily be repaired by the skin itself but intense exposure over
long time with neglecting the use of emollient creams may lead to an alteration of
the skin barrier and a subsequent inflammation in the skin. This inflammation,
irritant contact dermatitis, is together with its allergy based counterpart, allergic
contact dermatitis, the cause of important skin diseases since they are of great
economical consequence for the society and persons afflicted. Contact dermatitis,
often located to the hands, affects large numbers of persons and often have a long
duration which leads to sick leave for extended periods. Hand dermatitis may also
be a serious functional handicap at work and may also be socially bothering.
Irritant contact dermatitis is often seen in special risk groups where persons with
an atopic disposition have the highest risk of developing hand eczema. The risk of
developing irritant hand eczema is also associated with certain occupations
77
involving exposure of the hands to defatting agents such as organic solvents, oils,
cutting fluids, detergents and water leads to dryness and often to development of
irritant contact dermatitis. The prevalence of hand eczema is around 11% in a
normal population (7). In the risk occupations it is considerably higher as a result
of the exposure to food, wet work, irritant and defatting agents. Example of these
risk occupations are nurses, nurses aids, cleaners, machine operators, dentists and
dental nurses, mechanics, hairdressers and cooks.
Allergic contact dermatitis is a cell mediated allergy to low molecular weight
(<500) chemicals. It is an acquired alteration of reaction in the immune system.
Usually it is a chemical that has been handled and tolerated for a long time that
suddenly gives rise to a dermatitis. During this period the sensitization takes place
which gives rise to the allergy. Subsequent exposures will induce an allergic
response, allergic contact eczema, at the site of contact. This dermatitis can be
induced on the whole skin and the allergy usually lasts for the rest of the life.
There is no predisposition known and contact allergy can be induce in all persons.
The symptoms of the disease, the allergic contact eczema, can be treated and
cured by local treatment with steroids and avoidance of exposure but the allergy
will still be present and renewed contact will result in a relapse of the sickness and
a new eczema.
Prevention of adverse effects from dermal exposure is acquired from avoidance
of exposure. It is done with rigorous occupational hygienic measures often in
combination with wearing the proper protective clothes (5, 13). Selection of
proper protective gloves is important and has to take into account the exposing
chemical, work situation and comfort of the worker (8). Proper skin care is also of
great importance. Choosing mild soaps and using emollient creams on the hands
after work will reduce the risk of local reactions from dermal exposure (6).
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Introduction
Dermal exposure is a major route of systemic exposure at work. Along with
reductions in OELs and occupational exposure via air, the dermal route has
become even more important. In addition, there is a growing use of and interest
in transdermal drug delivery, for example of nicotine as a help to quit smoking,
and in using dermal permeation enhancers.
Many toxic effects occur only after systemic exposure (direct effects on the skin
are treated in the previous charter ”Dermal exposure”, by Boman A). The steps
between the presence of a chemical in the environment to systemic exposure may
be divided in two phases (Figure 1). The first phase is the relation between the
chemical’s presence and the exposure of skin (amount, area, duration). This
relation is affected by a number of factors, such as the properties of the chemical,
the work process, the individual’s behaviour and work practices, type of clothing
and protective equipment, etc. The influence of some of these factors may be
highly random and is often difficult to predict. The second phase is that from
exposure of the skin to systemic exposure. This relation depends on the properties
of the chemical and of the skin and is more easily described. It should, however,
be remembered that the properties of the skin may also vary thus affecting the
absorption rate and systemic exposure.
There is a wide range of absorption rates reported for the same chemical (Figure
2). This reflects the need for standardized approaches. In view of the many
sources of variability that are not directly related to the chemical per se, it might
be wise to focus on the intrinsic properties of the chemical, i.e. determine dermal
absorption rates for a large number of chemicals using standardized methods.
Fick’s law
The driving force for dermal absorption of chemicals is diffusion and Fick’s law
can be applied. The relation may be written as:
P = Kp x ( A1 - A2 )
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where P is the absorption rate, Kp is a permeability coefficient and A1 and A2 are
the thermodynamic activities (or partial pressures) of the chemical outside and
inside the skin, respectively. The absorption rate or net flux may be expressed
either as amount per time unit (e.g. µmol/h) or as amount per time and area unit
(e.g. µmol/h/cm2).
At low concentrations, the molecules are dispersed and do not interact, and
activity can be substituted by concentration. At high concentrations, the molecules
begin to interact. This reduces the diffusivity and the activity (and partial pres-
sure) becomes sublinear and approaches a plateau value-saturation concentration
(Figure 3). In many cases, for instance if there is a spill or splash of solvent on the
skin, the activity at the inner side may be approximated to zero. The value of Kp
depends on the properties of both the skin and the chemical. The numerical value
(and units) of Kp also depends on the units chosen for P and whether activity,
partial pressure, or concentration is used.
In summary, the penetration rate is directly proportional to the:
– concentration (activity, partial pressure) of the chemical at the skin surface,
– area exposed,
– permeability of the skin.
The permeability is mainly determined by the
– properties of the chemical,
– properties of the vehicle (if present),
– thickness of the keratin layer in stratum corneum,
– condition of the skin.
Figure 1. The relation between presence of chemical in the environment and systemic
exposure via skin.
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Figure 2. Reported dermal absorption rates vary by several orders of magnitude between
different industrial chemicals. Each dot represents one chemical. Reported values for the
same chemical may also vary greatly (vertical bars). Note the logarithmic scale. Adapted
from (2).
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Figure 3. The dermal absorption rate is proportional to the activity and (at low
concentrations) the concentration gradient over the skin.
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The keratin layer varies considerably between species and between different
parts of the body. It is therefore important to measure dermal absorption under
standardized conditions, in order to obtain comparable results.
The activity (and partial pressure) depends not only on the concentration of
the chemical but also on the properties of the vehicle. Thus, one chemical may
express high dermal penetration when dissolved in water and low penetration
when dissolved in vegetable oil. Another chemical may show the opposite
behaviour. The vehicle (as well as the chemical itself) may also change the pro-
perties of the skin, thus affecting penetration via a change in the permeability
coefficient.
Conditions of the skin that may affect the penetration include the:
– the degree of hydration,
– defatted skin,
– physical damage, wounds, cracks, and eczema.
Per cent absorbed dose and absorption rate at steady-state
The per cent dose absorbed is often used as a descriptor of a chemical’s ability to
penetrate the skin. The value obtained depends on a variety of factors, including:
exposed area, exposure duration, applied dose, and occlusion. The per cent dose
absorbed is therefore difficult to interpret. A better alternative is to apply chemical
in excess on a defined area and then determine the lag time for penetration and the
absorption rate at steady state. This can be done both in vitro and in vivo.
Dermal absorption in vitro
Dermal absorption may be measured in vitro using a Franz’ cell (Figure 4). The
cell is thermostatted to skin temperature and consists of a donor chamber con-
taining the chemical and a receptor chamber with physiological saline or another
suitable medium. The chemical has to penetrate a skin flap to reach the receptor
chamber. The lag time and absorption rate at steady state is calculated by mass-
balance from the concentration-time curve of chemical in the receptor medium.
The shape of the curve will depend on whether a static or dynamic (flow-through)
receptor chamber is used.
Dermal absorption in vivo
The lag time and absorption rate can be obtained in a similar way from in vivo
experiments (Figure 5). In this case the dynamic receptor chamber corresponds to
the whole body and, although the mass-balance over the skin is essentially the
same, the toxicokinetic analysis becomes more complicated. Instead of volume
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and receptor medium flow rate, the rates of redistribution and metabolism has to
be known. It may be convenient to use a physiologically-based pharmacokinetic
(pbpk) model in this kind of analysis.
32°C water bath
Applied chemicalSkin flap
Clamp
Receptor medium
Figure 4. The Franz’ cell for dermal absorption studies in vitro. Left: Static receptor
chamber. Right: Dynamic receptor chamber.
Figure 5. Dermal absorption experiments in vivo. Left: Exposure of one hand to liquid.
A ventilated box is used to eliminate inhalation exposure to vapours. Right: Whole-body
exposure to vapour. Air masks are used to eliminate inhalation exposure.
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Dermal uptake of vapours
The skin is designed to protect from water losses and is relatively impermeable
compared to the lung. The latter is designed for rapid gas exchange, has a large
surface area, and is highly permeable. Dermal uptake of vapours and gases is
therefore in most cases negligible (below a few per cent) compared to inhalation
uptake. Important exceptions to this rule are organic solvents with low vapour
pressure, good solubility in skin, and good penetration properties, such as nitro
compounds and glycol ethers.
Calculation of dermal absorption rate by structure-activity
analysis
For a given piece of skin, the absorption rate is largely determined by the polarity
and diffusivity, i.e. the structure, of the molecule. Many structure-activity equa-
tions have been proposed, for example:
where P is the absorption rate, Kow the octanol:water partition coefficient, and MW
the molar weight (1). Structure-activity equations generally give good predictions
within a class of chemicals or homologous series (e.g. alcohols) but severely
erroneous predictions may be obtained when moving from one group to another.
Criteria for skin notation
There are two useful criteria for skin notation:
1. a defined (area, duration, etc) skin exposure increases the systemic dose by
a given percentage, compared to inhalation exposure at the OEL, and/or
2. realistic dermal exposure at the workplace has been shown to cause
adverse effects.
Vague criteria (Table 1) and lack of good data have lead to different classifica-
tions for the same chemical by different authorities and organisations (Table 2).
An additional problem is that substances, even those with a skin notation, vary by
several orders of magnitude in their ability to penetrate the skin. Thus, there is a
need to characterise chemicals in a more informative way than in the simple
yes/no (skin notation or not) fashion presently used.
MW0061.0Klog71.03.6Plog ow −+−=
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Table 1. Criteria for assigning a skin notation in different countries.
Denmark “When known that the substance can be absorbed via skin”
Norway “Substances that can be taken up via skin”
Finland “Absorbed amounts and health risks cannot be evaluated only
from air concentrations”
Sweden “Substances easily taken up by the body via skin”
Germany (MAK) “When dermal exposure increases the body burden”
European Union (SCOEL) “Substantial contribution to total body burden via dermal
exposure”
USA (ACGIH ) “Potential significant contribution to overall exposure...”
The Netherlands (DECOS) “More than 10% contribution to total exposure...”
European industry (ECETOC) “More than 10% contribution to total exposure...”
Table 2. The skin notation differs by country for several chemicals. Adapted from (2).
SWE NL ACGIH GER UK NO DK FIN SCOEL
2000 2001 2001 2000 2001 2000 2000 1998 1998
Butanone 2- no S no S no S S S no S S no S –
Benzyl acetate – – no S – – – – – –
Butyl acetate no S no S no S no S no S no S no S no S –
Cyanide S S S S S S S S –
DEGBE no S S – no S – – no S – –
DEGBEAc no S no S – – – – – – –
DEGEE S S – – – – – – –
Dichloromethane S no S no S no S no S no S S no S –
Dimethylethylamine no S no S – no S no S no S no S no S –
Dinitrobenzene S S S S S S S S –
EGBE S S S S S S S S S
EGEEAc S S S S S S S S –
EGiPE S S – S – no S no S – –
Ethanol no S no S no S no S no S no S no S no S –
Ethylbenzene no S S no S S no S no S no S no S S
Ethylene glycol S no S no S S no S no S S no S S
Furfural S no S S S S S S S –
Methanol S S S S S S S S no S
n-Butanol S no S S no S S no S S S –
PGME S no S no S S S no S no S no S –
PGMEAc S no S – no S no S S no S S S
Phenol S S S S S S S S S
Propanol 1- no S – no S – S S S no S –
Styrene S no S no S no S no S no S S no S –
Tetrachloroethylene 1,1,1,2- no S S no S S no S S S no S –
Tetrahydrofuran no S S no S no S S no S S no S S
Thiourea no S S – no S – – – – –
Toluene S no S S S S S S S –
Trichloroethane 1,1,1- no S no S no S no S no S no S no S S no S
Trichloroethane 1,1,2- – no S S S – S S no S –
Trichloroethylene 1,1,2- no S no S no S no S S no S no S no S –
Xylene S S no S S S S S S S
S = skin notation.
no S = no skin notation.
– = not listed.
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Dermal uptake index
One alternative to skin notation would be to use an index, i.e. the ratio between
dermal and inhalation uptake under specified conditions.
inh
skin
P
P
IndexDermal =
, where Pskin is the absorption rate via skin at steady-state, and Pinh is the absorption
rate via inhalation during exposure at the OEL (3). The absolute value of the index
will depend on chemical dependent factors (penetrating properties and OEL of the
chemical) and chemical-independent factors (area and region of skin, pulmonary
ventilation, and pulmonary retention), which have to be fixed. As seen in Figure 6,
the dermal index varies by several orders of magnitude for different industrial
chemicals. Thus, the index gives more quantitative information than a yes/no as in
traditional skin notation.
Figure 6. Dermal uptake indices calculated for industrial chemicals (same as in Figure 2).
Each point represents one chemical. Note the logarithmic scale. Adapted from (2).
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Exposure to particles and lung disease
Vidar Skaug, Department of Toxicology, National Institute of Occupational
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Introduction
Particulate substances in the air at the workplace may be present as dust (fine
particles of dry matter), mist (liquid droplets in gases) or as components of fumes
(very fine dusts in gases, particularly air as a result of a chemical or thermal
processes). If inhaled by the workers they may cause physiological, biochemical
or histopathological abnormalities in the respiratory system. Other organ systems
such as the cardiovascular system may also be affected if the particles or their
components are translocated to sensitive receptor sites at other locations. There is
growing interest for effects on the cardiovascular system from inhaled dust
particles (11, 24). The purpose of this paper is to discuss some aspects of particle
induced respiratory diseases in relation to risk assessment and occupational
exposure limits.
Uncertain statistics for occupational exposures and lung disease
Occupational diseases are underestimated in Norway. Using pneumoconiosis as
an example, only less than 10 cases of silicosis have been reported annually to the
authorities since 1990. The corresponding notifications for asbestosis are 60-100,
with no decreasing trend. Mineral particle induced lung diseases occur from a few
years up to decades after onset of exposure, depending on the cumulative dose.
For the last 10 years the occupational exposure limit (OEL) for respirable quartz
dust and asbestos fibres have been 0.1 mg/m3 and 0.1 fibres/ml, respectively.
Earlier the limits were 0.2 mg/m3 for quartz and 2 fibres/ml for asbestos. In this
period, there has been change in technologies, automation of industrial processes
and less dust at most, but not all workplaces, whereas many dusty industries
have shut down. Although the database EXPO on occupational exposures at the
National Institute of Occupational Health does not include representative nation-
wide samples, it shows that the median quartz dust levels have been well below
the OEL during the last decade. The highest exposures to respirable quarts dust
today are found in construction industries during drilling in rocks.
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OELs and inhaled particles
Health based OELs are generally based on responses observed in human volun-
teers, epidemiological studies or in laboratory animals. A major determinant for
the toxic effects of particulate pollution is the size distribution of the particles in
the air at the workplace, since size also determines deposition on to the airway
surfaces, clearances from these sites, translocation to the underlying epithelium,
and inherent toxicity to some extent. Other particle related factors for pulmonary
toxicity and adverse affects are: chemical composition, durability in the lung
tissues, the biological or mineralogical origin, whether natural or synthetic,
amorphous or crystalline, surface characteristic, elemental composition and
structure. Mineral particles presenting as mineral fibres have different biological
properties compared to their non-fibrous counterpart. Impurities and absorbed
pollutants should also be taken into account in the assessment of toxicity.
Sampling of airborne particulates for risk assessment and health
surveillance
The proportion of particles at the workplace which is inhaled into the human body
depends on the properties of the particles, on air movements near the body, and
whether breathing is through the nose or mouth. Inhaled particles can deposit in
different parts of the airways depending on the properties of the particles, the
respiratory tract and breathing pattern. Since the deposition site is related to
particle size, the adverse health effects may also be related to the deposition site.
The European Standard defines standards and criteria for particle size-selective
dust sampling to be used to for collecting airborne particles at the workplace (14).
The sampling conventions are derived from experimental data in healthy adults,
to be used for setting OELs to protect the mean worker. For comparisons of
deposition probabilities for particles with various sizes, shapes and densities, the
particles are characterized by their aerodynamic diameter (dae) which is defined as
the diameter of a sphere with density 1 g/cm3 which sediments at the same rate as
the particle in calm air.
The Standard defines five size specific mass fractions of total airborne particles
that can be sampled for health risk assessment and regulatory purposes; 1) particle
mass fractions inhaled through the mouth and nose (inhalable fraction), 2) the
fraction failing to penetrate beyond the larynx (extrathoracic fraction), 3) the
fraction penetrating beyond the larynx (thoracic fraction), 4) beyond the larynx
but failing to penetrate to the gas exchange region (tracheobronchial fraction), and
lastly 5) penetrating to the gas exchange region of the lung ( respirable fraction).
The conventions are defined for inhalable, thoracic and respirable fractions. These
conventions are illustrated in Figure 1. Extrathoracic and tracheobronchial frac-
tions are calculated from these three defined conventions.
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Figure 1. Conventions for size-specific mass fractions of total airborn particles.
Respirable dust particles
Respirable dust is thus airborne particulate material that is capable of penetrating
to the gas-exchange region of the lungs. In occupational settings it is collected as
PM4 (the mass of particles present in the air having a 50% cut-off for particles
with an aerodynamic diameter of 4 µm). Occupational exposures include particles
such as asbestos and other silicates, silica, coal mine dust, cadmium and other
metal fumes, organic particles and smaller particulate matter (PM) without clearly
defined chemical composition.
PM10  and PM2.5
These modes are used primarily for Ambient Air Quality Standards for particulate
matter (13). PM10 is the mass of particles present in the air having a 50% cut-off
for particles with an aerodynamic diameter of 10 µm. It is the standard measure
for respirable particles used for ambient air particulates (10). They also occur at
the workplace. There are two partly overlapping modes (13), with a sharp cut at
2.5 µm in order to be able to analyse the concentrations of fine and coarse parti-
cles separately.
The coarse mode, PM2.5 - 10, is formed from large solids and/or droplets. In
ambient air they may occur as mechanical disruption products from soil or soil
like sources. In occupational settings they occur through grinding or crushing of
solids, abrasion of surfaces or evaporation of sprays. They are produced during
welding, sandblasting and mining. Other exposures occur during farming and
work with bio aerosols.
The fine mode consists of smaller particles, measured as PM2.5 (the mass of
particles present in the air having a 50% cut-off for particles with an aerodynamic
diameter of 2.5 µm). They are formed by chemical reactions predominantly from
combustion sources, nucleation, and condensations of gases and coagulation of
smaller particles. The particles are very numerous and represent large surface
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areas, compared to mass. The chemical composition is less uniform. Typically it
results from combustions of fossil fuels and high temperature industrial processes
such as welding, soldering, and smelting. There is good correlation between PM2.5
and particle dimensions found in the respiratory system of urban dwellers (4).
For some occupational exposures there are mixtures of respirable particles, such
as coal particles from different sources. In coal mines a 0.8 µm cut-off is used,
with almost all of the diesels exhaust particles laying below that cut size and
almost all of the coal dust lying above it.
Ultrafine (Very very fine) particles
These are still finer particles within the respirable fraction. The term refers to
particles less than 0.1 µm. They are constituents of ambient air and occur regu-
larly in some occupational exposures such as metal fumes and polymer fumes.
The number of particles and total surface area are large compared to mass.
Mixed exposures
Although lower than in the past, exposures today are generally more complex
and mixed. Smoking lung cancer patients retain more mineral particles in the
peripheral airways compared to non-smokers, thus increasing the risk for toxic
effects in peripheral airways (5). Inversely, for quartz particles in cell cultures, the
inflammatory effect is decreased in the presence of excess aluminium (12). The
lower exposure levels of quarts today, often in conjunction with other particulates,
notably aluminium silicates, induce less fibrosis in the airways, lung or pleura,
and not the full-blown picture of silicosis.
Inhaled particles: airways defence and failure
The ciliated cells of the airway epithelium are covered by mucous which embeds
deposited particles and clear them towards the pharynx and the gastrointestinal
tract. This airway defence system is impaired by prolonged inhalation of pol-
lutants. Irritation and cytotoxic effects may induce lesions in the cells of the
respiratory epithelium which can slough off, followed by regeneration, squamous
cell metaplasia thus further preventing the transport of particles upwards.
In the gas exchange region of the lung there are no ciliated cells. Phagocytosis
and secretion by alveolar macrophages represents the primary defence line in
these regions, and thereafter the phagocytic cells gain access to the mucociliary
escalator. The phagocytic rate depends on size, morphology and surface character-
ristics of the particles. Mineral fibres longer than 15-20 µm are incompletely
phagocytized. Many factors are involved in the phagocytic process. Highly
cytotoxic particles such as quartz are less readily cleared through phagocytosis
than less toxic particles. Ultrafine poorly soluble particles impair phagocytosis in
cell cultures to a greater extent than fine particles on a mass basis (26). Human
alveolar macrophage function is also impaired after exposure to ultrafine carbon
particles (18). When the ultrafine particles escape phagocytosis, they can penetrate
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the epithelial cells and induce toxicity or pass through the epithelial lining of the
airways into the interstitial spaces and induce acute inflammation.
Particle overload
Ideally chronic exposures and subsequent dose levels results in lung burdens
without adverse effects; the no-observed-effect-level (NOEL). This happens when
the particle deposition rate is equal to or lower than the pulmonary clearance rate.
However, when the clearance rate is exceeded, the particle burden may build up
in the lung tissues. This overload is due mainly to impairment of the macrophage
mediated clearance function (19). In chronic rat inhalation studies this overload
has been shown to produce chronic inflammation in the airways and lung tissue,
resulting in pulmonary fibrosis and tumours. Mice and hamsters also accumulate
particles at the same exposure concentrations, but there is less inflammation and
no tumours have been observed, due to more efficient protection towards inflam-
matory induced oxidative DNA-damage (17). The role of clearance impairment
and overload in humans is not settled. There seems to be a good overall correla-
tion between the fraction of dust deposited in the lung lobes and the frequency of
lung cancer in the same lobes ( 28). On the other hand, coal workers chronically
exposed to very high dust levels, rates of lung tumours are not significantly
increased (16). Histological examination of lung tissues in general also indicates
that they can accumulate a considerable burden of dust without adverse effect.
Concurrent toxic exposures, such as smoking which impairs clearance, needs to
be studied further.
Particle accumulation in the respiratory system
Respiratory bronchioles accumulate particularly high particle loads, typically
25-100 times the concentrations seen in the main stem bronchus. Similarly high
concentrations are found in the large airway carina’s, suggesting that these
locations are likely sites for particle toxicity. Ultrafine particles, which are asso-
ciated with toxicity of particulate matter in experimental situations, are present in
small numbers as single particles and are largely metals. They represent perhaps
combustion products, but carbonaceous chain aggregates are rarely found. Mean
particle aerodynamic diameters vary from about 0.3 to 0.6 µm in different parts
of the airways. Overall the airways retain PM2.5 rather than PM10, a finding
supporting the observation that, in some studies, adverse health effects appear
to correlate better with PM2.5 than with PM10 (4).
Dust particles are found in alveolar and interstitial macrophages, the peribron-
chial perivascular, the subpleural connective tissues, in the lymphatic vessels,
and lymph nodes. The major mineral species found in the normal lungs of urban
dwellers are silicates and silica (29). Mineral fibres constitute less than 10% of
the total mineral dust burden (5). The size distribution of non-fibrous minerals
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extracted from the human lung is 0.6-0.73 µm (6, 7, 29). The dust load is
positively correlated with age (29) and smoking (5).
Adverse health effects
Reflex responses from inhaled particles
Inhaled particles, with or without chemical irritants absorbed to the surface, may
interact with the rich innervations of the airway linings. Depending on particle
characteristics, this interaction produces reflex changes in breathing patterns,
including coughing, sneezing and bronchial constriction. Other effects are reduc-
tion in ventilation rates and volumes, and excess secretion of mucus (1). Other
effects such as intoxication, unpleasant smells or pain, may act to prevent further
exposure of the respiratory tract.
Diseases of the respiratory tract and related to particle size
Some particles exert immediate local effects (irritation, corrosion) at the site of
deposition, whereas others are translocated to other parts of the respiratory tract
where they are absorbed or cause a biological effect. Although not always the
case, particle size predicts the site and type of primary response. Examples are
effects in the head airways region by particles within the inhalable fraction, such
as rhinitis due to pollen allergens or fungi with large dae and carcinoma of the nose
and nasal cavities due to wood dust. Particles within the thoracic fraction can be
deposited in the conducting airways and contribute to exacerbations of asthma, the
development or progression of chronic bronchitis and bronchial cancer. Even
more distally, in the gas exchange region of the lung, pneumoconiosis or alveolitis
is induced by particles within the respirable fraction.
Ambient air PM10 is associated with increased mortality in adults (9), a finding
that is not consistent in all studies (27). In children, there is evidence of bronchitis
(8) and decreased lung function (25). The fine particles PM 2.5 are well correlated
with increased mortality among sensitive individuals in the population. The fine
mode has not been considered for OELs since occupational exposures have not
been sufficiently studied.
In animal experiments ultrafine particles like Teflon or titanium dioxide less
than 0.05 µm produced much stronger inflammatory responses than 0.5 µm
particles with the same mass concentrations (11, 21, 22). Also ultrafine poly-
styrene particles are more biological active compared to fine particles with the
same mass. Oxidative stress can cause this enhanced activity (3). It has not been
settled yet whether particle count is a more appropriate measure related to health
effects than the particle mass used for larger particles (20). Solubility and uptake
into pulmonary cells play an important role because of the small particles.
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Asthma
Asthma is characterized by chronic inflammation of the airways, and intermittent
airway obstruction as determined by reduced FEV1. Particles within the thoracic
fraction may act as inducers or as provokers of asthma. Allergens in animal hou-
ses are among the most potent inducers and provokers of asthma; levels around
1 ng/m3 may cause asthma attacks. Exposure to flour proteins in the range 1-100
µg/m3 is likely to cause IgE mediated respiratory symptoms. Once sensitized,
inhalation of very low doses may cause an attack, but even when the dose is
insufficient to cause an attack, it may worsen the airway inflammation and
hypersensitivity.
For some low molecular weight chemicals at the work place such as anhydrides
and isocyanates, where the mechanisms of sensitization are not solely IgE media-
ted exposures, exposures to 1-100 µg/m3 cause respiratory symptoms.
It is not possible to set an OEL that fully protects already sensitized individuals.
When scientifically justifiable an OEL could aim at avoiding new cases for
defined allergens, when the mechanism of sensitization and dose-response rela-
tionships for these are known. In one study of asthma due to prepolymerized
isocyanates in smoking spray painters, peak exposures and not mean exposures,
were correlated with impairment in lung function (31). More research is needed
on this important issue, as a basis for OEL setting.
Non-allergic particles worsen asthma at exposure concentrations often above
1000 mg/m3. The non-allergic reactive airways dysfunction syndrome (RADS)
may be caused by even higher concentrations. Epidemiological studies do not
show that increases in PM10 elevated the risk for sensitization and induction of
asthma (10). Mechanisms of diesel exhaust particle-induced allergy and asthma
have been suggested form animal data (30), but it is not known whether these
apply in humans (23).
Small Airways Disease
There are two major forms of small airways disease associated with inhalation of
dusts and fumes, both are associated with chronic obstructive lung disease. The
most common is respiratory bronchiolitis associated with cigarette smoking, in
which there is chronic inflammation in the small airways associated with mild
fibrosis, variable smooth muscle hyperplasia, accumulation of carbonaceous
material and tan pigmented macrophages in the respiratory bronchioles and
adjacent alveolar ducts. The other form is mineral dust-associated small airways
disease. Typically deposits of mineral particles are found in the walls of small
airways and alveolar ducts, particularly at their bifurcations. The fibrosis may be
prominent and extend further into the alveoli (32). These adverse effects in the
airways are also seen jointly with interstitial fibrosis due to fibrogenic dusts.
94
Pulmonary fibrosis
Weakly fibrogenic dusts, such as coal dust, carbon black and titanium dioxide,
deposited in the walls of the respiratory bronchioles are associated with mild and
predominantly reticulin fibrosis and centriacinar emphysema. There is little
disruption of the normal tissue structures and scant interstitial fibrosis, in contrast
to the collagen rich fibrosis due to highly fibrogenic dusts such as quarts and
asbestos fibres. Pneumoconiotic nodules in the lungs are characteristic for the
pulmonary response to silica and silicates, but also to the less fibrogenic dusts
such as in coal workers pneumoconiosis. Diffuse interstitial fibrosis is the primary
response to fibrous dusts (e.g. asbestos) but is also seen to some extent following
exposure to silica, silicates and coal dust (2). There is a dose-effect relationship
between exposure to the minerals and the degree of lung fibrosis, but not for the
advanced stages complicated by super infections, progressive massive fibrosis or
by end-stage lung.
Pulmonary fibrosis appears to involve complex interactions between proinflam-
matory and anti-inflammatory forces. Many studies have confirmed the role of
endogenous and exogenous reactive oxygen species, other free radical species and
proinflammatory cytokine releases, in particle induced chronic inflammatory
processes and fibrosis.
The low OELs for quartz is not only due to the higher fibrogenic potential, but
also because it is classified as a carcinogen. It is still a matter of debate whether
pulmonary fibrosis is a mechanistic step in tumour induction by quartz and
asbestos.
Carcinogenic effects
Inhaled poorly soluble fibrous and non-fibrous particles may interact with the
cells in the respiratory epithelium and induce lung tumours by two different
mechanisms. Firstly some particles are associated with primary genotoxic effects,
and thus induce tumour formation through a non-threshold mechanism. Humans
exposed to such particles are at increased risk, since any amount of these direct-
acting carcinogens in theory can cause mutation. Secondly tumours may arise as a
result of cytotoxicity, inflammation and increased cell proliferation. The particles
may then act through a threshold mechanism. Humans exposed are not at increa-
sed risk when exposure concentrations do not induce inflammation and do not
overcome the antioxidant and DNA repair capacity of the lung (15). Continuous
animal inhalation studies with a variety of poorly soluble particles, TiO2, quarts,
or diesel exhaust particles, leading to overload and chronic inflammation of the
lung and airways, have shown lung tumour induction (17). Inflammation is
however not a prerequisite for mineral fibre carcinogenicity since all inhalable
fibres seem to produce chronic inflammation at continuous inhalation over time
beyond a certain level, but not all of them are carcinogens.
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Standards for particles at the workplace and in ambient air
In occupational health the OELs are generally chemical specific, but not for
particles with low toxicity (nuisance dusts). Particles at the workplace will not
always have a homogeneous chemical composition, and there may be differences
in size distributions for one dust in different occupational settings. The use of
OELs for risk assessment and worker protection must be done knowing the
pitfalls.
Opposite, for ambient air quality standards in the US there are only six defined
chemical standards, whereas the standard for particulate matter is not specified in
terms of chemical composition. For fine and ultrafine particles mass and chemical
composition may thus be less important than the high particles numbers, for the
health outcomes.
For ultrafine particles there are no regulatory standards neither for ambient air
nor at the workplace, due to poor understanding of the adverse health effects in
humans and that techniques for measuring them has not fully emerged. More
clarification is needed on exposures and effects for these particle fractions.
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Occupational exposure limits and mixed
exposures
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Abstract
In general, occupational exposure limits (OELs) are set for single chemicals and
for more or less defined complex chemical mixtures such as, for instance, wood
dust and welding fumes. To properly assess the potential health risks of chemical
mixtures, it is essential to understand the basic concepts similar joint action, dis-
similar joint action (with positive or negative correlation of susceptibility) and
interaction of combinations of chemicals. It is equally important to distinguish
between simple, defined mixtures at the one hand, and complex mixtures at the
other hand.
In some countries, it has been recognised that in occupational standard setting
consideration should be given to combined effects of simple, defined mixtures of
two or more chemicals, using the appropriate formulas for assessing whether or
not exposure to such mixtures at a given workplace is of health concern.
Recently, a scheme has been developed for the safety evaluation of complex
mixtures. Two conspicuous elements of this scheme are the dichotomy of complex
mixtures into mixtures that are virtually unavailable and mixtures that are readily
available for testing in their entirety, and the identification of the n (say, ten) most
risky chemicals or most risky classes of chemicals in the mixture. A workplace
atmosphere is an excellent example of a complex mixture virtually unavailable
for testing in its entirety. Once the (limited number of) most risky chemicals or
classes of chemicals have been identified, a safety evaluation of the mixture
of these selected chemicals (or pseudo chemicals each of which represents an
identified class of chemicals) can be performed, using procedures suitable for
hazard identification and risk assessment of simple, defined mixtures. In brief,
the safety evaluation of a (complex) workplace atmosphere can be tackled by
evaluating the safety of the defined mixture of its major (most risky) constituents.
Introduction
Humans are exposed concurrently and sequentially to hundred thousands of
chemicals from very different sources such as food, drinking water, beverages,
occupation, indoor and outdoor air, soil and consumer products. Thus, mixed
exposures are everywhere and are the rule rather than the exception, indicating
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hazard identification and risk assessment should focus on mixtures rather than on
single chemicals (5, 12). However, until recently about 95% of the sources in toxi-
cology were devoted to the exception, viz. single chemicals (22). Although all of
this is true, there is another aspect of exposure to chemical mixtures that should
not be overlooked: chemical mixtures are characteristic of life, and in a way our
body can be regarded as a big reaction vessel with a complex, well structured,
highly organised content. When we eat and breathe, we feed into this reaction
vessel several hundred thousands of chemicals at the same time. As far as we can
judge, as a rule (healthy) humans (and animals) apparently have learned to deal
with simultaneous exposure to huge numbers of chemicals. In fact, exposure to
certain chemical mixtures, for instance essential nutrients, drinking water and air
are vital. Consequently, the focus in toxicology, including occupational toxicology
should not be just on mixtures but on priority mixtures, priority being determined
by (potential) risk rather than by toxicity (9).
The vast majority of occupational exposure limits (OELs) relates to single
chemicals, and notes of warning for potential risks due to simultaneous exposure
to certain other chemicals are generally lacking. However, OELs have been set for
a small number of more or less defined complex mixtures such as e.g. wood dust,
rubber solvent, stoddard solvent, welding fumes, asphalt fumes, coal dust and
cotton dust. According to the American Conference of Governmental Industrial
Hygienists (ACGIH), primary consideration should be given to the combined
effects of mixed exposures to two or more chemicals which act on the same target
organ (1). In the absence of information to the contrary, such effects should
be considered as additive and the additivity rule should be applied to find out
whether or not mixed exposure at a specific workplace is of health concern. The
same rule is applied in Sweden (20). In the Netherlands, the same rule is also
applied but only for chemicals with the same target organ and the same mecha-
nism of action (21). The ACGIH (1) explicitly states that the additivity rule should
not be used for mixtures of which the individual chemicals affect different organs,
and ACGIH further explains that in such cases the formula for independent effects
should be used to judge whether a specific mixed exposure situation is of health
concern. Several countries recognise that synergistic action may occur with some
combinations of chemicals, and observe that such cases must be dealt with on a
case-by-case basis (1, 20). Awareness of the possibility of synergistic effects is,
according to the Swedish National Board of Occupational Safety and Health (20),
reason enough to keep occupational exposure concentrations as low as possible.
The German “MAK-Kommission” refuses to use simple rules for calculating
OELs (6). However, the German committee is willing to consider the recommen-
dation of OELs for defined, specific mixtures of great practical importance on the
basis of the committee’s own studies. The Scientific Committee on Occupational
Exposure Limits (SCOEL) of the European Union (EU) does not derive OELs
for such mixtures but when mixed exposure is of particular significance at the
workplace the SCOEL will make a note to that effect in the documentation sum-
marising the recommendations for the individual chemicals in question (8). For
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details on the formulas to be used for assessing the potential health concern of the
different types of mixed exposures, the reader is reffered to ACGIH (1).
To be able to properly assess the potential health risks of chemical mixtures, it
is essential to understand the basic concepts of joint action and interaction of
combinations of chemicals (18), and to distinguish between simple and complex
chemical mixtures (10). These aspects will be briefly discussed in the present
paper. Moreover, the major conclusions of a series of experimental studies rele-
vant to safety evaluation of chemical mixtures will be presented.
Basic concepts
Some 50 years ago pioneers in the field of toxicology of chemical mixtures
defined three basic types of action for combinations of chemicals that are still
valid today (18):
Similar joint action
This form of action is also referred to as dose addition. Similar joint action is non-
interactive, which means that the chemicals in the mixture do not influence each
other’s toxicity. Each chemical in the mixture contributes to the toxicity of the
mixture in proportion to its dose, expressed as the percentage of the dose of that
chemical alone which would be required to obtain the given effect of the mixture.
All chemicals in the mixture act in the same way, by the same mechanism of
action, and differ only in their potencies. This concept of joint action also serves
as the basis for the use of toxic equivalency factors (TEFs).
Dissimilar joint action
This form of action is also non-interactive. Thus, the chemicals in the mixture do
not affect the toxicity of one another. However, the modes of action and possibly
but not necessarily, the nature and the site of the toxic effect differ among the
chemicals in the mixture. This form of action is also referred to as independent
joint action or response addition. For this mode of action it is important to under-
stand the concept “correlated susceptibility”. Two different concepts have been
formulated: complete positive correlation and complete negative correlation of
susceptibility. Assume a mixture consists of two chemicals X and Y. In case of
complete positive correlation, individuals most susceptible to toxicant X are also
most susceptible to toxicant Y. The toxicity of the mixture X + Y will be deter-
mined by the chemical with the highest concentration, and the proportion of
individuals responding to the mixture will be equal to the response to the most
toxic agent in the mixture. If, for instance doses of X and Y result in 15 and 25%
deaths, respectively, the mixture of X + Y will result in 25% deaths. In case of
complete negative correlation, individuals most susceptible to X are least suscep-
tible to Y. The percentage of the individuals responding to the mixture will be
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equal to the sum of the response to X and the response to Y. If, for instance the
doses of X and Y result in 15 and 25% deaths, respectively, the mixture of X + Y
will result in 40% deaths.
Interaction
All deviations from the former two concepts are defined as interactions. The term
“interaction” describes the combined effect between chemicals resulting in a
stronger effect (synergism, potentiation, supra-additivity) or weaker effect (anta-
gonism, sub-additivity, inhibition) than expected on the basis of additivity.
These basic principles of joint action of chemicals and interaction between
chemicals in a mixture are theoretical. In reality, however, one will most likely
have to deal with these various concepts at the same time, especially when mix-
tures consist of more than two, say 10 or more compounds. For more details on
these basic concepts and their application in safety evaluation of mixtures, the
reader is referred to a review by Cassee et al.(5).
Simple and Complex Mixtures
A simple mixture consists of a relatively small number of chemicals, say ten or
less, and its composition is qualitatively and quantitatively known. Examples are
a cocktail of pesticides, a combination of medicines, and a combination of food
additives. A complex mixture consists of tens, hundreds or thousands of chemicals
and its composition is qualitatively and quantitatively not fully known. Examples
are welding fumes, wood dust, drinking water, environmental tobacco smoke, and
a workplace atmosphere.
Simple, Defined Mixtures
Lessons from studies with simple, defined mixtures.
During the past 15 years, at TNO we carried out a series of toxicity studies in
rats with various types of simple, defined mixtures, ranging from mixtures of
arbitrarily chosen chemicals to mixtures of chemicals with the same target organ
(kidney, nose) and with the same or different mode of action, mixtures of myco-
toxins, and mixtures of sensory irritants (3, 4, 5, 11, 12, 14, 15). One of the major
objectives of this research programme on mixtures was to test the hypothesis
that as a rule exposure to mixtures of chemicals at (low) non-toxic doses of the
individual chemicals is of no health concern (11). Three main conclusions that
could be drawn from these studies are:
– joint or interactive effects seen at clearly toxic-effect-levels of the indi-
vidual chemicals do not predict the joint or interactive effects that might
occur at or below the highest-no-toxic-effect-levels of the individual
compounds,
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– dose addition is appropriate for hazard and risk assessment of a mixture
of chemicals with similar joint action,
– exposure to a mixture of chemicals with different modes of action does
not constitute an evidently increased hazard compared to that of exposure
to the individual chemicals, provided the exposure level of each chemical
in the mixture is at most similar to its own “no observed adverse effect
level”. Expressed in terms of potential risk this conclusion reads: if the
combined action of chemicals in a mixture meets the criteria of dissimilar
joint action, the health risk of such a mixture is determined by the health
risk associated with the “most risky chemical” (= the chemical with the
highest risk quotient) in the mixture, provided the risk quotients of the
other chemicals in the mixture are at most equal to unity.
In hazard identification and risk assessment, these lessons should be taken into
account on a case-by-case basis.
Hazard identification and risk assessment
For hazard identification and risk assessment of simple, defined mixtures a wide
variety of methods is available, ranging from whole mixture analysis (top-down
approach) to component joint action or interaction analysis (bottom-up approach)
(5, 12). A most promising method for quantitative risk assessment of defined
mixtures is the so-called hazard index/weight of evidence (HI/WOE) approach
(19). This method combines the HI ( = exposure concentration divided by the
OEL) of the individual compounds with weighing factors for aspects such as
mechanistic understanding of binary joint actions or interactions, type and degree
of toxicity, relevance of route of exposure, and availability of in vitro data. In
its most recent version (2, 7), this method also takes into account the relative
exposure levels of the chemicals in the mixture which is regarded as a major
improvement of the original version (16).
Complex Mixtures
It is self-evident that for studying the toxicology of complex mixtures the bottom-
up approach is virtually impossible. The top-down approach may be appropriate
for some complex mixtures such as for instance welding fume and recycled drink-
ing water, for others such as for instance the atmosphere at a hazardous waste site
or a workplace atmosphere, whole mixture analysis seems to be impracticable and
meaningless. A scheme for hazard identification and risk assessment of complex
mixtures has been developed some years ago (10), and has recently been refined
(13, 16). This scheme is depicted, in slightly modified form, in Figure 1. Two
conspicuous elements of this scheme are the dichotomy of complex mixtures into
mixtures that are virtually unavailable and mixtures that are readily available for
testing in their entirety, and the “top-n” and “pseudo top-n” approaches. The
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“top-n” approach means identification in a complex mixture of the n (say, the ten)
most risky (not most toxic!) chemicals, and the “pseudo top-n” approach means
identification of the n most risky classes of chemicals (for each class a pseudo
chemical is identified, using the so-called lumping technique). Once these chemi-
cals or pseudo chemicals have been identified they will be approached as a
simple, defined mixture, assuming that hazard and potential risk of the n selected
chemicals or pseudo chemicals are representative for the hazard and risk of the
entire complex mixture (10, 16). A comparable approach is successfully being
used in the United States to identify the priority substances that are released from
hazardous waste sites and that pose the greatest hazard to human health. Once the
most risky chemicals have been identified, their potential health risk is assessed as
a mixture, using a narrative weight-of-evidence approach incorporating mecha-
nistic insights on possible joint actions or interactions (17). The “top-n” and
“pseudo top-n” approaches seem to be particularly suitable for the toxicological
evaluation of workplace atmospheres (11).
Concluding Remarks
When evaluating the safety of chemical mixtures, it is meaningful to distinguish
between at the one hand simple, defined mixtures consisting of a relatively small
number of chemicals, (say, ten or less) of which the quantitative composition is
known, and on the other hand complex mixtures consisting of hundreds or many
thousands of mostly unknown chemicals. For safety evaluation of simple mixtures
a number of methods is available based on the basic principles dose addition,
response addition or interaction (5, 12). For safety evaluation of complex mixtures
a scheme has been developed, including a category of mixtures described as “vir-
tually unavailable for testing in their entirety” (10, 13). Workplace atmospheres
are examples of this type of complex mixtures. They can be approached by
identifying the, say, ten or in more general terms the n most risky chemicals at a
particular workplace (the top n identification). Once these priority chemicals have
been identified, a safety evaluation of the mixture of these selected most risky
chemicals can be performed, using procedures that have been described for
hazard identification and risk assessment of simple, defined mixtures. Other than
suggested by ACGIH (1), generally applicable OELs for such simple mixtures
cannot be established. In brief, safety evaluation of a specific workplace atmos-
phere can be tackled by evaluating the safety of the defined mixture of the major
(most risky) constituents (11). A similar approach is successfully being used in the
United States for hazard identification and risk assessment of the mixture of
chemicals that is released from hazardous waste sites (17).
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Summary
Johanson G (ed). Occupational exposure limits – approaches and criteria.
Proceedings from a NIVA course held in Uppsala, Sweden, 24-28 September
2001. Arbete och Hälsa 2003;17:1-109.
This volume presents selected lectures given at the course Occupational exposure
limits – approaches and criteria, third international course. The main objectives
were to: describe and differentiate between the various approaches and criteria
used to set an occupational exposure limit (OEL) identify the problems of
comparing OELs from different countries, and analyse an OEL based on back-
ground information. The course was arranged by the Nordic Expert Group for
Criteria Documentation of Health Risks from Chemicals (NEG) and the Nordic
Institute for Advanced Training in Occupational Health (NIVA).
The presentations herein cover: basic concepts in toxicological risk assessment,
information retrieval, criteria documents as basis for OELs, OEL setting by the
European Union, the Netherlands, Sweden and the American Conference on
Governmental Industrial Hygienists (ACGIH), scientific, socioeconomic, techno-
logical and ethical aspects, exposure to particles and lung disease, and mixed
exposures. Several other topics were also addressed at the course.
Key words: chemical hazards, criteria document, dermal exposure, mixed
exposure, occupational exposure limit, risk assessment, skin notation, toxicology,
work environment.
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Summary in Swedish
Johanson G (ed). Occupational exposure limits – approaches and criteria.
Proceedings from a NIVA course held in Uppsala, Sweden, 24-28 September
2001. Arbete och Hälsa 2003;17:1-109.
Denna volym innehåller ett urval av de föredrag som hölls vid kursen
Occupational exposure limits – approaches and criteria, third international
course. Målsättningen med kursen var att beskriva och differentiera mellan olika
tillvägagångssätt att sätta hygieniska gränsvärden (HGV) för arbetsmiljön,
identifiera svårigheter med att jämföra HGV från olika länder samt att analysera
ett HGV baserat på bakgrundsinformation. Kursen anordnades av Nordiska
expertgruppen för kriteriedokument om kemiska hälsorisker (NEG) och Nordiska
institutet för vidareutbildning i arbetsmiljö (NIVA).
Föreliggande presentationer täcker bland annat: grunderna i toxikologisk
riskbedömning, informationssökning, kriteriedokument som underlag för HGV,
gränsvärdessättning inom europeiska unionen, Nederländerna, Sverige och
American Conference on Governmental Industrial Hygienists (ACGIH),
vetenskapliga, socioekonomiska, tekniska och etiska aspekter, exponering för
partiklar och lungsjukdom, samt blandexponering. Många andra ämnen
behandlades också under kursen.
Nyckelord: arbetsmiljö, blandexponering, hudexponering, hudmärkning,
hygieniskt gränsvärde, kemiska hälsorisker, kriteriedokument, riskbedömning,
toxikologi.
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